<!DOCTYPE html>
<html lang="en" class="no-js">
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="applicable-device" content="pc,mobile">
        <meta name="viewport" content="width=device-width, initial-scale=1">

        <title>Cyclin D1 cooperates with p21 to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion | Breast Cancer Research | Full Text</title>

        

    <meta name="citation_abstract" content="Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGF&#946;) in breast cancer progression. Cyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion. We found TGF&#946; to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGF&#946;-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGF&#946;-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGF&#946; promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the in vivo studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21. Thus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGF&#946;-mediated tumor growth initiation and local tumor cell invasion, both in vitro and in vivo.">

    <meta name="journal_id" content="13058">

    <meta name="dc.title" content="Cyclin D1 cooperates with p21 to regulate TGF&#946;-mediated breast cancer cell migration and tumor local invasion">

    <meta name="dc.source" content="Breast Cancer Research 2013 15:3">

    <meta name="dc.format" content="text/html">

    <meta name="dc.publisher" content="BioMed Central">

    <meta name="dc.date" content="2013-06-20">

    <meta name="dc.type" content="OriginalPaper">

    <meta name="dc.language" content="En">

    <meta name="dc.copyright" content="2013 Dai et al.; licensee BioMed Central Ltd.">

    <meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0">

    <meta name="dc.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="dc.description" content="Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGF&#946;) in breast cancer progression. Cyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion. We found TGF&#946; to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGF&#946;-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGF&#946;-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGF&#946; promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the in vivo studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21. Thus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGF&#946;-mediated tumor growth initiation and local tumor cell invasion, both in vitro and in vivo.">

    <meta name="prism.issn" content="1465-542X">

    <meta name="prism.publicationName" content="Breast Cancer Research">

    <meta name="prism.publicationDate" content="2013-06-20">

    <meta name="prism.volume" content="15">

    <meta name="prism.number" content="3">

    <meta name="prism.section" content="OriginalPaper">

    <meta name="prism.startingPage" content="1">

    <meta name="prism.endingPage" content="14">

    <meta name="prism.copyright" content="2013 Dai et al.; licensee BioMed Central Ltd.">

    <meta name="prism.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="prism.url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3441">

    <meta name="prism.doi" content="doi:10.1186/bcr3441">

    <meta name="citation_pdf_url" content="https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3441">

    <meta name="citation_fulltext_html_url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3441">

    <meta name="citation_journal_title" content="Breast Cancer Research">

    <meta name="citation_journal_abbrev" content="Breast Cancer Res">

    <meta name="citation_publisher" content="BioMed Central">

    <meta name="citation_issn" content="1465-542X">

    <meta name="citation_title" content="Cyclin D1 cooperates with p21 to regulate TGF&#946;-mediated breast cancer cell migration and tumor local invasion">

    <meta name="citation_volume" content="15">

    <meta name="citation_issue" content="3">

    <meta name="citation_publication_date" content="2013/06">

    <meta name="citation_online_date" content="2013/06/20">

    <meta name="citation_firstpage" content="1">

    <meta name="citation_lastpage" content="14">

    <meta name="citation_article_type" content="Research article">

    <meta name="citation_fulltext_world_readable" content="">

    <meta name="citation_language" content="en">

    <meta name="dc.identifier" content="doi:10.1186/bcr3441">

    <meta name="DOI" content="10.1186/bcr3441">

    <meta name="citation_doi" content="10.1186/bcr3441">

    <meta name="description" content="Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGF&#946;) in breast cancer progression. Cyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion. We found TGF&#946; to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGF&#946;-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGF&#946;-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGF&#946; promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the in vivo studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21. Thus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGF&#946;-mediated tumor growth initiation and local tumor cell invasion, both in vitro and in vivo.">

    <meta name="dc.creator" content="Dai, Meiou">

    <meta name="dc.creator" content="Al-Odaini, Amal A">

    <meta name="dc.creator" content="Fils-Aim&#233;, Nad&#232;ge">

    <meta name="dc.creator" content="Villatoro, Manuel A">

    <meta name="dc.creator" content="Guo, Jimin">

    <meta name="dc.creator" content="Arakelian, Ani">

    <meta name="dc.creator" content="Rabbani, Shafaat A">

    <meta name="dc.creator" content="Ali, Suhad">

    <meta name="dc.creator" content="Lebrun, Jean Jacques">

    <meta name="dc.subject" content="Cancer Research">

    <meta name="dc.subject" content="Oncology">

    <meta name="dc.subject" content="Surgical Oncology">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Cancer metastasis: building a framework; citation_author=GP Gupta, J Massague; citation_volume=127; citation_publication_date=2006; citation_pages=679-695; citation_doi=10.1016/j.cell.2006.11.001; citation_id=CR1">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=The pathogenesis of cancer metastasis: the &#39;seed and soil&#39; hypothesis revisited; citation_author=IJ Fidler; citation_volume=3; citation_publication_date=2003; citation_pages=453-458; citation_doi=10.1038/nrc1098; citation_id=CR2">

    <meta name="citation_reference" content="citation_journal_title=Nat Biotechnol; citation_title=Lost in migration; citation_author=GS Mack, A Marshall; citation_volume=28; citation_publication_date=2010; citation_pages=214-229; citation_doi=10.1038/nbt0310-214; citation_id=CR3">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Mechanisms of TGF-beta signaling from cell membrane to the nucleus; citation_author=Y Shi, J Massague; citation_volume=113; citation_publication_date=2003; citation_pages=685-700; citation_doi=10.1016/S0092-8674(03)00432-X; citation_id=CR4">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer; citation_author=B Bierie, HL Moses; citation_volume=6; citation_publication_date=2006; citation_pages=506-520; citation_doi=10.1038/nrc1926; citation_id=CR5">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast; citation_author=C Scheel, EN Eaton, SH Li, CL Chaffer, F Reinhardt, KJ Kah, G Bell, W Guo, J Rubin, AL Richardson, RA Weinberg; citation_volume=145; citation_publication_date=2011; citation_pages=926-940; citation_doi=10.1016/j.cell.2011.04.029; citation_id=CR6">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis; citation_author=M Labelle, S Begum, RO Hynes; citation_volume=20; citation_publication_date=2011; citation_pages=576-590; citation_doi=10.1016/j.ccr.2011.09.009; citation_id=CR7">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Targeting the TGF beta signaling network in human neoplasia; citation_author=N Dumont, CL Arteaga; citation_volume=3; citation_publication_date=2003; citation_pages=531-536; citation_doi=10.1016/S1535-6108(03)00135-1; citation_id=CR8">

    <meta name="citation_reference" content="citation_journal_title=Nat Genet; citation_title=TGF-beta signaling in tumor suppression and cancer progression; citation_author=R Derynck, RJ Akhurst, A Balmain; citation_volume=29; citation_publication_date=2001; citation_pages=117-129; citation_doi=10.1038/ng1001-117; citation_id=CR9">

    <meta name="citation_reference" content="citation_journal_title=Trends Cell Biol; citation_title=TGF-beta signaling in cancer--a double-edged sword; citation_author=RJ Akhurst, R Derynck; citation_volume=11; citation_publication_date=2001; citation_pages=S44-51; citation_id=CR10">

    <meta name="citation_reference" content="citation_journal_title=Curr Opin Genet Dev; citation_title=TGF-beta signaling: positive and negative effects on tumorigenesis; citation_author=LM Wakefield, AB Roberts; citation_volume=12; citation_publication_date=2002; citation_pages=22-29; citation_doi=10.1016/S0959-437X(01)00259-3; citation_id=CR11">

    <meta name="citation_reference" content="citation_journal_title=Nat Cell Biol; citation_title=Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility; citation_author=S Giampieri, C Manning, S Hooper, L Jones, CS Hill, E Sahai; citation_volume=11; citation_publication_date=2009; citation_pages=1287-1296; citation_doi=10.1038/ncb1973; citation_id=CR12">

    <meta name="citation_reference" content="citation_journal_title=Nat Struct Biol; citation_title=The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization; citation_author=BM Chacko, B Qin, JJ Correia, SS Lam, MP de Caestecker, K Lin; citation_volume=8; citation_publication_date=2001; citation_pages=248-253; citation_doi=10.1038/84995; citation_id=CR13">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell; citation_title=Structural basis of heteromeric smad protein assembly in TGF-beta signaling; citation_author=BM Chacko, BY Qin, A Tiwari, G Shi, S Lam, LJ Hayward, M de Caestecker, K Lin; citation_volume=15; citation_publication_date=2004; citation_pages=813-823; citation_doi=10.1016/j.molcel.2004.07.016; citation_id=CR14">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling; citation_author=Y Shi, YF Wang, L Jayaraman, H Yang, J Massague, NP Pavletich; citation_volume=94; citation_publication_date=1998; citation_pages=585-594; citation_doi=10.1016/S0092-8674(00)81600-1; citation_id=CR15">

    <meta name="citation_reference" content="citation_journal_title=EMBO J; citation_title=Transcriptional control by the TGF-beta/Smad signaling system; citation_author=J Massague, D Wotton; citation_volume=19; citation_publication_date=2000; citation_pages=1745-1754; citation_doi=10.1093/emboj/19.8.1745; citation_id=CR16">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Mol Cell Biol; citation_title=TGFbeta signalling in context; citation_author=J Massague; citation_volume=13; citation_publication_date=2012; citation_pages=616-630; citation_doi=10.1038/nrm3434; citation_id=CR17">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=G1 cell-cycle control and cancer; citation_author=J Massague; citation_volume=432; citation_publication_date=2004; citation_pages=298-306; citation_doi=10.1038/nature03094; citation_id=CR18">

    <meta name="citation_reference" content="citation_journal_title=Dev Cell; citation_title=CDK inhibitors: cell cycle regulators and beyond; citation_author=A Besson, SF Dowdy, JM Roberts; citation_volume=14; citation_publication_date=2008; citation_pages=159-169; citation_doi=10.1016/j.devcel.2008.01.013; citation_id=CR19">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=G1 phase progression: cycling on cue; citation_author=CJ Sherr; citation_volume=79; citation_publication_date=1994; citation_pages=551-555; citation_doi=10.1016/0092-8674(94)90540-1; citation_id=CR20">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1; citation_author=S Bates, L Bonetta, D MacAllan, D Parry, A Holder, C Dickson, G Peters; citation_volume=9; citation_publication_date=1994; citation_pages=71-79; citation_id=CR21">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Association of human cyclin E with a periodic G1-S phase protein kinase; citation_author=V Dulic, E Lees, SI Reed; citation_volume=257; citation_publication_date=1992; citation_pages=1958-1961; citation_doi=10.1126/science.1329201; citation_id=CR22">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle; citation_author=A Koff, A Giordano, D Desai, K Yamashita, JW Harper, S Elledge, T Nishimoto, DO Morgan, BR Franza, JM Roberts; citation_volume=257; citation_publication_date=1992; citation_pages=1689-1694; citation_doi=10.1126/science.1388288; citation_id=CR23">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Identification of G1 kinase activity for cdk6, a novel cyclin D partner; citation_author=M Meyerson, E Harlow; citation_volume=14; citation_publication_date=1994; citation_pages=2077-2086; citation_doi=10.1128/MCB.14.3.2077; citation_id=CR24">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins; citation_author=H Matsushime, ME Ewen, DK Strom, JY Kato, SK Hanks, MF Roussel, CJ Sherr; citation_volume=71; citation_publication_date=1992; citation_pages=323-334; citation_doi=10.1016/0092-8674(92)90360-O; citation_id=CR25">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest [see comments]; citation_author=GJ Hannon, D Beach; citation_volume=371; citation_publication_date=1994; citation_pages=257-261; citation_doi=10.1038/371257a0; citation_id=CR26">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4; citation_author=M Serrano, GJ Hannon, D Beach; citation_volume=366; citation_publication_date=1993; citation_pages=704-707; citation_doi=10.1038/366704a0; citation_id=CR27">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function; citation_author=KL Guan, CW Jenkins, Y Li, MA Nichols, X Wu, CL O&#39;Keefe, AG Matera, Y Xiong; citation_volume=8; citation_publication_date=1994; citation_pages=2939-2952; citation_doi=10.1101/gad.8.24.2939; citation_id=CR28">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6; citation_author=H Hirai, MF Roussel, JY Kato, RA Ashmun, CJ Sherr; citation_volume=15; citation_publication_date=1995; citation_pages=2672-2681; citation_doi=10.1128/MCB.15.5.2672; citation_id=CR29">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases; citation_author=JW Harper, GR Adami, N Wei, K Keyomarsi, SJ Elledge; citation_volume=75; citation_publication_date=1993; citation_pages=805-816; citation_doi=10.1016/0092-8674(93)90499-G; citation_id=CR30">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=WAF1, a potential mediator of p53 tumor suppression; citation_author=WS el-Deiry, T Tokino, VE Velculescu, DB Levy, R Parsons, JM Trent, D Lin, WE Mercer, KW Kinzler, B Vogelstein; citation_volume=75; citation_publication_date=1993; citation_pages=817-825; citation_doi=10.1016/0092-8674(93)90500-P; citation_id=CR31">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals; citation_author=K Polyak, MH Lee, H Erdjument-Bromage, A Koff, JM Roberts, P Tempst, J Massague; citation_volume=78; citation_publication_date=1994; citation_pages=59-66; citation_doi=10.1016/0092-8674(94)90572-X; citation_id=CR32">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21; citation_author=H Toyoshima, T Hunter; citation_volume=78; citation_publication_date=1994; citation_pages=67-74; citation_doi=10.1016/0092-8674(94)90573-8; citation_id=CR33">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene; citation_author=S Matsuoka, MC Edwards, C Bai, S Parker, P Zhang, A Baldini, JW Harper, SJ Elledge; citation_volume=9; citation_publication_date=1995; citation_pages=650-662; citation_doi=10.1101/gad.9.6.650; citation_id=CR34">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution; citation_author=MH Lee, I Reynisdottir, J Massague; citation_volume=9; citation_publication_date=1995; citation_pages=639-649; citation_doi=10.1101/gad.9.6.639; citation_id=CR35">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=CDK inhibitors: positive and negative regulators of G1-phase progression; citation_author=CJ Sherr, JM Roberts; citation_volume=13; citation_publication_date=1999; citation_pages=1501-1512; citation_doi=10.1101/gad.13.12.1501; citation_id=CR36">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA; citation_author=Y Xiong, H Zhang, D Beach; citation_volume=71; citation_publication_date=1992; citation_pages=505-514; citation_doi=10.1016/0092-8674(92)90518-H; citation_id=CR37">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins; citation_author=ZK Yu, JL Gervais, H Zhang; citation_volume=95; citation_publication_date=1998; citation_pages=11324-11329; citation_doi=10.1073/pnas.95.19.11324; citation_id=CR38">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=TGFbeta in Cancer; citation_author=J Massague; citation_volume=134; citation_publication_date=2008; citation_pages=215-230; citation_doi=10.1016/j.cell.2008.07.001; citation_id=CR39">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta; citation_author=I Reynisdottir, K Polyak, A Iavarone, J Massague; citation_volume=9; citation_publication_date=1995; citation_pages=1831-1845; citation_doi=10.1101/gad.9.15.1831; citation_id=CR40">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation; citation_author=J Seoane, HV Le, L Shen, SA Anderson, J Massague; citation_volume=117; citation_publication_date=2004; citation_pages=211-223; citation_doi=10.1016/S0092-8674(04)00298-3; citation_id=CR41">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=p21 in cancer: intricate networks and multiple activities; citation_author=T Abbas, A Dutta; citation_volume=9; citation_publication_date=2009; citation_pages=400-414; citation_doi=10.1038/nrc2657; citation_id=CR42">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Cyclin D as a therapeutic target in cancer; citation_author=EA Musgrove, CE Caldon, J Barraclough, A Stone, RL Sutherland; citation_volume=11; citation_publication_date=2011; citation_pages=558-572; citation_doi=10.1038/nrc3090; citation_id=CR43">

    <meta name="citation_reference" content="citation_journal_title=Breast Cancer Res; citation_title=A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion; citation_author=M Dai, AA Al-Odaini, A Arakelian, SA Rabbani, S Ali, JJ Lebrun; citation_volume=14; citation_publication_date=2012; citation_pages=R127; citation_doi=10.1186/bcr3322; citation_id=CR44">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer; citation_author=R Agarwal, AM Gonzalez-Angulo, S Myhre, M Carey, JS Lee, J Overgaard, J Alsner, K Stemke-Hale, A Lluch, RM Neve, WL Kuo, T Sorlie, A Sahin, V Valero, K Keyomarsi, JW Gray, AL Borresen-Dale, GB Mills, BT Hennessy; citation_volume=15; citation_publication_date=2009; citation_pages=3654-3662; citation_doi=10.1158/1078-0432.CCR-08-3293; citation_id=CR45">

    <meta name="citation_reference" content="citation_journal_title=Cell Cycle; citation_title=RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response; citation_author=A Ertel, JL Dean, H Rui, C Liu, AK Witkiewicz, KE Knudsen, ES Knudsen; citation_volume=9; citation_publication_date=2010; citation_pages=4153-4163; citation_doi=10.4161/cc.9.20.13454; citation_id=CR46">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone; citation_author=M Drobnjak, I Osman, HI Scher, M Fazzari, C Cordon-Cardo; citation_volume=6; citation_publication_date=2000; citation_pages=1891-1895; citation_id=CR47">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas; citation_author=P Jares, PL Fernandez, E Campo, A Nadal, F Bosch, G Aiza, I Nayach, J Traserra, A Cardesa; citation_volume=54; citation_publication_date=1994; citation_pages=4813-4817; citation_id=CR48">

    <meta name="citation_reference" content="citation_journal_title=J Clin Invest; citation_title=Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors; citation_author=AJ Minn, Y Kang, I Serganova, GP Gupta, DD Giri, M Doubrovin, V Ponomarev, WL Gerald, R Blasberg, J Massagu&#233;; citation_volume=115; citation_publication_date=2005; citation_pages=44-55; citation_doi=10.1172/JCI22320; citation_id=CR49">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell; citation_title=Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex; citation_author=DI Lin, O Barbash, KG Kumar, JD Weber, JW Harper, AJ Klein-Szanto, A Rustgi, SY Fuchs, JA Diehl; citation_volume=24; citation_publication_date=2006; citation_pages=355-366; citation_doi=10.1016/j.molcel.2006.09.007; citation_id=CR50">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation; citation_author=JR Alt, JL Cleveland, M Hannink, JA Diehl; citation_volume=14; citation_publication_date=2000; citation_pages=3102-3114; citation_doi=10.1101/gad.854900; citation_id=CR51">

    <meta name="citation_reference" content="citation_journal_title=Mol Biol Cell; citation_title=Cyclin D1 governs adhesion and motility of macrophages; citation_author=P Neumeister, FJ Pixley, Y Xiong, H Xie, K Wu, A Ashton, M Cammer, A Chan, M Symons, ER Stanley, RG Pestell; citation_volume=14; citation_publication_date=2003; citation_pages=2005-2015; citation_doi=10.1091/mbc.02-07-0102; citation_id=CR52">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling; citation_author=Z Li, C Wang, X Jiao, Y Lu, M Fu, AA Quong, C Dye, J Yang, M Dai, X Ju, X Zhang, A Li, P Burbelo, ER Stanley, RG Pestell; citation_volume=26; citation_publication_date=2006; citation_pages=4240-4256; citation_doi=10.1128/MCB.02124-05; citation_id=CR53">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells; citation_author=Z Zhong, WS Yeow, C Zou, R Wassell, C Wang, RG Pestell, JN Quong, AA Quong; citation_volume=70; citation_publication_date=2010; citation_pages=2105-2114; citation_doi=10.1158/0008-5472.CAN-08-1108; citation_id=CR54">

    <meta name="citation_reference" content="citation_journal_title=J Cell Biol; citation_title=Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia; citation_author=M Schoumacher, RD Goldman, D Louvard, DM Vignjevic; citation_volume=189; citation_publication_date=2010; citation_pages=541-556; citation_doi=10.1083/jcb.200909113; citation_id=CR55">

    <meta name="citation_reference" content="citation_journal_title=Clin Exp Metastasis; citation_title=Invadopodia: specialized cell structures for cancer invasion; citation_author=AM Weaver; citation_volume=23; citation_publication_date=2006; citation_pages=97-105; citation_doi=10.1007/s10585-006-9014-1; citation_id=CR56">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway; citation_author=RJ Lee, C Albanese, M Fu, M D&#39;Amico, B Lin, G Watanabe, GK Haines, PM Siegel, MC Hung, Y Yarden, JM Horowitz, WJ Muller, RG Pestell; citation_volume=20; citation_publication_date=2000; citation_pages=672-683; citation_doi=10.1128/MCB.20.2.672-683.2000; citation_id=CR57">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Specific protection against breast cancers by cyclin D1 ablation; citation_author=Q Yu, Y Geng, P Sicinski; citation_volume=411; citation_publication_date=2001; citation_pages=1017-1021; citation_doi=10.1038/35082500; citation_id=CR58">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Mouse development and cell proliferation in the absence of D-cyclins; citation_author=K Kozar, MA Ciemerych, VI Rebel, H Shigematsu, A Zagozdzon, E Sicinska, Y Geng, Q Yu, S Bhattacharya, RT Bronson, K Akashi, P Sicinski; citation_volume=118; citation_publication_date=2004; citation_pages=477-491; citation_doi=10.1016/j.cell.2004.07.025; citation_id=CR59">

    <meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=Cyclin D1 in breast cancer pathogenesis; citation_author=A Arnold, A Papanikolaou; citation_volume=23; citation_publication_date=2005; citation_pages=4215-4224; citation_doi=10.1200/JCO.2005.05.064; citation_id=CR60">

    <meta name="citation_reference" content="citation_journal_title=Endocrinology; citation_title=Minireview: Cyclin D1: normal and abnormal functions; citation_author=M Fu, C Wang, Z Li, T Sakamaki, RG Pestell; citation_volume=145; citation_publication_date=2004; citation_pages=5439-5447; citation_doi=10.1210/en.2004-0959; citation_id=CR61">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=A census of amplified and overexpressed human cancer genes; citation_author=T Santarius, J Shipley, D Brewer, MR Stratton, CS Cooper; citation_volume=10; citation_publication_date=2010; citation_pages=59-64; citation_doi=10.1038/nrc2771; citation_id=CR62">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues; citation_author=H Matsubayashi, N Sato, N Fukushima, CJ Yeo, KM Walter, K Brune, F Sahin, RH Hruban, M Goggins; citation_volume=9; citation_publication_date=2003; citation_pages=1446-1452; citation_id=CR63">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation; citation_author=E Evron, CB Umbricht, D Korz, V Raman, DM Loeb, B Niranjan, L Buluwela, SA Weitzman, J Marks, S Sukumar; citation_volume=61; citation_publication_date=2001; citation_pages=2782-2787; citation_id=CR64">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation; citation_author=A Padar, UG Sathyanarayana, M Suzuki, R Maruyama, JT Hsieh, EP Frenkel, JD Minna, AF Gazdar; citation_volume=9; citation_publication_date=2003; citation_pages=4730-4734; citation_id=CR65">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice; citation_author=TC Wang, RD Cardiff, L Zukerberg, E Lees, A Arnold, EV Schmidt; citation_volume=369; citation_publication_date=1994; citation_pages=669-671; citation_doi=10.1038/369669a0; citation_id=CR66">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis; citation_author=MW Landis, BS Pawlyk, T Li, P Sicinski, PW Hinds; citation_volume=9; citation_publication_date=2006; citation_pages=13-22; citation_doi=10.1016/j.ccr.2005.12.019; citation_id=CR67">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Requirement for CDK4 kinase function in breast cancer; citation_author=Q Yu, E Sicinska, Y Geng, M Ahnstrom, A Zagozdzon, Y Kong, H Gardner, H Kiyokawa, LN Harris, O Stal, P Sicinski; citation_volume=9; citation_publication_date=2006; citation_pages=23-32; citation_doi=10.1016/j.ccr.2005.12.012; citation_id=CR68">

    <meta name="citation_reference" content="citation_journal_title=Am J Pathol; citation_title=The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer; citation_author=C Yang, V Ionescu-Tiba, K Burns, M Gadd, L Zukerberg, DN Louis, D Sgroi, EV Schmidt; citation_volume=164; citation_publication_date=2004; citation_pages=1031-1038; citation_doi=10.1016/S0002-9440(10)63190-2; citation_id=CR69">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer; citation_author=A Russell, MA Thompson, J Hendley, L Trute, J Armes, D Germain; citation_volume=18; citation_publication_date=1999; citation_pages=1983-1991; citation_doi=10.1038/sj.onc.1202511; citation_id=CR70">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1; citation_author=S Benzeno, F Lu, M Guo, O Barbash, F Zhang, JG Herman, PS Klein, A Rustgi, JA Diehl; citation_volume=25; citation_publication_date=2006; citation_pages=6291-6303; citation_doi=10.1038/sj.onc.1209644; citation_id=CR71">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Cyclin D1 gene (CCND1) mutations in endometrial cancer; citation_author=G Moreno-Bueno, S Rodriguez-Perales, C Sanchez-Estevez, D Hardisson, D Sarrio, J Prat, JC Cigudosa, X Matias-Guiu, J Palacios; citation_volume=22; citation_publication_date=2003; citation_pages=6115-6118; citation_doi=10.1038/sj.onc.1206868; citation_id=CR72">

    <meta name="citation_reference" content="citation_journal_title=J Cell Physiol; citation_title=Nuclear cyclin D1: an oncogenic driver in human cancer; citation_author=JK Kim, JA Diehl; citation_volume=220; citation_publication_date=2009; citation_pages=292-296; citation_doi=10.1002/jcp.21791; citation_id=CR73">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function; citation_author=C Wang, Z Li, Y Lu, R Du, S Katiyar, J Yang, M Fu, JE Leader, A Quong, PM Novikoff, RG Pestell; citation_volume=103; citation_publication_date=2006; citation_pages=11567-11572; citation_doi=10.1073/pnas.0603363103; citation_id=CR74">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Cyclin D1 determines mitochondrial function in vivo
                                    ; citation_author=T Sakamaki, MC Casimiro, X Ju, AA Quong, S Katiyar, M Liu, X Jiao, A Li, X Zhang, Y Lu, C Wang, S Byers, R Nicholson, T Link, M Shemluck, J Yang, ST Fricke, PM Novikoff, A Papanikolaou, A Arnold, C Albanese, R Pestell; citation_volume=26; citation_publication_date=2006; citation_pages=5449-5469; citation_doi=10.1128/MCB.02074-05; citation_id=CR75">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation; citation_author=C Wang, N Pattabiraman, JN Zhou, M Fu, T Sakamaki, C Albanese, Z Li, K Wu, J Hulit, P Neumeister, PM Novikoff, M Brownlee, PE Scherer, JG Jones, KD Whitney, LA Donehower, EL Harris, T Rohan, DC Johns, RG Pestell; citation_volume=23; citation_publication_date=2003; citation_pages=6159-6173; citation_doi=10.1128/MCB.23.17.6159-6173.2003; citation_id=CR76">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization; citation_author=M Yasui, H Yamamoto, CY Ngan, B Damdinsuren, Y Sugita, H Fukunaga, J Gu, M Maeda, I Takemasa, M Ikeda, Y Fujio, M Sekimoto, N Matsuura, IB Weinstein, M Monden; citation_volume=12; citation_publication_date=2006; citation_pages=4720-4729; citation_doi=10.1158/1078-0432.CCR-05-1213; citation_id=CR77">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Cyclin D1 induction of cellular migration requires p27(KIP1); citation_author=Z Li, X Jiao, C Wang, X Ju, Y Lu, L Yuan, MP Lisanti, S Katiyar, RG Pestell; citation_volume=66; citation_publication_date=2006; citation_pages=9986-9994; citation_doi=10.1158/0008-5472.CAN-06-1596; citation_id=CR78">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers; citation_author=S Jirawatnotai, Y Hu, W Michowski, JE Elias, L Becks, F Bienvenu, A Zagozdzon, T Goswami, YE Wang, AB Clark, TA Kunkel, T van Harn, B Xia, M Correll, J Quackenbush, DM Livingston, SP Gygi, P Sicinski; citation_volume=474; citation_publication_date=2011; citation_pages=230-234; citation_doi=10.1038/nature10155; citation_id=CR79">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export; citation_author=JR Alt, AB Gladden, JA Diehl; citation_volume=277; citation_publication_date=2002; citation_pages=8517-8523; citation_doi=10.1074/jbc.M108867200; citation_id=CR80">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Alternative cyclin D1 splice forms differentially regulate the DNA damage response; citation_author=Z Li, X Jiao, C Wang, LA Shirley, H Elsaleh, O Dahl, M Wang, E Soutoglou, ES Knudsen, RG Pestell; citation_volume=70; citation_publication_date=2010; citation_pages=8802-8811; citation_doi=10.1158/0008-5472.CAN-10-0312; citation_id=CR81">

    <meta name="citation_reference" content="citation_journal_title=J Cell Sci; citation_title=Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis; citation_author=E Raderschall, A Bazarov, J Cao, R Lurz, A Smith, W Mann, HH Ropers, JM Sedivy, EI Golub, E Fritz, T Haaf; citation_volume=115; citation_publication_date=2002; citation_pages=153-164; citation_id=CR82">

    <meta name="citation_author" content="Dai, Meiou">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Al-Odaini, Amal A">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author_institution" content="University of Dammam, Ministry of Higher Education, Kragujevac, Saudi Arabia">

    <meta name="citation_author" content="Fils-Aim&#233;, Nad&#232;ge">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Villatoro, Manuel A">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Guo, Jimin">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Arakelian, Ani">

    <meta name="citation_author_institution" content="Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Rabbani, Shafaat A">

    <meta name="citation_author_institution" content="Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Ali, Suhad">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">

    <meta name="citation_author" content="Lebrun, Jean Jacques">

    <meta name="citation_author_institution" content="Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada">



        <meta name="format-detection" content="telephone=no">

        
<link rel="apple-touch-icon" sizes="180x180" href=/static/img/favicons/bmc/apple-touch-icon-582ef1d0f5.png>
<link rel="icon" type="image/png" sizes="32x32" href=/static/img/favicons/bmc/favicon-32x32-5d7879efe1.png>
<link rel="icon" type="image/png" sizes="16x16" href=/static/img/favicons/bmc/favicon-16x16-c241ac1a2f.png>
<link rel="manifest" href=/static/app-bmc/manifest-3bb9ad383b.json>
<link rel="mask-icon" href=/static/img/favicons/bmc/safari-pinned-tab-427338756f.svg color="#e6e6e6">
<link rel="shortcut icon" data-test="shortcut-icon" href=/static/img/favicons/bmc/favicon-1886637b78.ico>
<meta name="msapplication-config" content=/static/app-bmc/browserconfig-ecd9aa8205.xml>
<meta name="msapplication-TileColor"
      content="#1b3051">
<meta name="msapplication-TileImage"
      content=/static/img/favicons/bmc/app-icon-144x144.png>
<meta name="theme-color"
      content="#1b3051">


        
        <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>

        


    
        <link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-article-cd4a428820.css>
    

    <link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-b076aec3c2.css>
    <link rel="stylesheet" media="print" href=/static/app-bmc/css/print-b8af42253b.css>
    

    

    
        <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;font-size:1.8em;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em}p:last-child{margin-bottom:0}p:empty{display:none}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:"";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:"";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px;text-decoration:none}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container{-webkit-box-align:center;-webkit-box-pack:justify;align-items:center;display:flex;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-header__brand{margin-right:48px}.c-header__brand a,.c-journal-title a{text-decoration:none}.c-header__menu,.c-header__navigation{display:flex}.c-header__navigation{-webkit-box-align:center;align-items:center}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff;margin-right:24px}.c-header__item:last-child{margin-right:0}.c-header__link{color:#fff;text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{-webkit-box-pack:justify;display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#0097ef;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{-webkit-box-flex:0;align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{-webkit-box-align:baseline;align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.42857;padding:16px 0}.c-navbar__container{-webkit-box-pack:justify;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__container,.c-navbar__content{-webkit-box-align:center;align-items:center;display:flex}.c-navbar__content{-webkit-box-flex:0;flex:0 1 auto}@media only screen and (min-width:1024px){.c-navbar__content{display:flex!important}}.c-navbar__nav{display:flex;list-style:none;margin:0;padding:0}@media only screen and (min-width:1024px){.c-navbar__nav{transform:translateY(1px)}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{-webkit-box-align:center;-webkit-box-pack:center;align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg{fill:currentcolor}.u-button{color:#004b83}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{-webkit-box-align:center;align-items:center}.u-flex-static{-webkit-box-flex:0;flex:0 1 auto;flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:18px;font-style:normal;line-height:1.4;margin-bottom:.7em}.u-h4{font-style:italic;font-weight:700}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}body{font-size:1.125rem} }</style>

        <link rel="stylesheet" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-2b5751e1cf.css"
              media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">

        <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { .c-reading-companion__figure-title,.u-h3,.u-h4{font-family:Georgia,Palatino,serif;font-style:normal;line-height:1.4}.u-h3{margin-bottom:1em}.u-h4{margin-bottom:1em}button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;font-size:1.8em;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em;overflow-wrap:break-word;word-break:break-word}p:last-child{margin-bottom:0}p:empty{display:none}.u-h3{font-size:1.75rem;font-size:1.5rem;font-weight:700}.c-reading-companion__figure-title{font-size:1.25rem;font-weight:700}.u-h4{font-size:1.25rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li,.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}.c-article-author-list__show-more{margin-right:4px}@media only screen and (max-width:539px){html.js .js-small-screen-show-inline{display:inline!important;visibility:visible!important}.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{-webkit-box-align:baseline;align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-reading-companion__figure-full-link svg{margin-left:4px}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;display:inline-block;font-size:.875rem;font-weight:700;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#0067c5;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title,.c-nature-box{line-height:1.3}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{-webkit-box-orient:horizontal;-webkit-box-direction:normal;display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{-webkit-box-flex:1;flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__figures-list,.c-reading-companion__references-list,.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1em;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{-webkit-box-pack:justify;display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{display:inline-block}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-article-associated-content__container .c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-reading-companion__panel--active{display:block}.c-pdf-download{display:flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{-webkit-box-pack:justify;-webkit-box-flex:1;background:#173962;border:1px solid transparent;border-radius:2px;color:#fff;display:flex;flex:1 1 0%;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:space-between;line-height:1.3;padding:13px 24px;text-decoration:none}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}@media only screen and (max-width:30em){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-associated-content__container a{text-decoration:underline}.c-article-associated-content__container .c-article-associated-content__collection.collection~.c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__title{display:none}.c-article-associated-content__container .c-article-associated-content__collection.collection,.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.collection{margin-top:28px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.c-article-main-column .c-pdf-download{display:none}@media only screen and (max-width:1023px){.c-article-main-column .c-pdf-download{display:block}}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif} }</style>
        <link rel="stylesheet" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-article-415bd1e493.css"
              media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">
    



        

        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: 'breast-cancer-research.biomedcentral.com',
            siteWithPath: 'breast-cancer-research.biomedcentral.com' + window.location.pathname,
            twitterHashtag: '',
            cmsPrefix: 'https://studio-cms.springernature.com/studio/',
            
            doi: '10.1186/bcr3441',
            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',
            hasFigshareInvoked: false,
            publisherBrand: 'BioMed Central',
            mustardcut: false
        };
    </script>

        
    <script type="text/javascript" data-test="dataLayer">
        window.dataLayer = [{"content":{"article":{"doi":"10.1186/bcr3441","articleType":"Research article","peerReviewType":"Closed","supplement":null,"keywords":"Cyclin D1;p21Cip1;Transforming growth factor beta (TGFÎ²);Breast cancer;Migration;Invasion"},"contentInfo":{"imprint":"BioMed Central","title":"Cyclin D1 cooperates with p21 to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion","publishedAt":1371686400000,"publishedAtDate":"2013-06-20","author":["Meiou Dai","Amal A Al-Odaini","NadÃ¨ge Fils-AimÃ©","Manuel A Villatoro","Jimin Guo","Ani Arakelian","Shafaat A Rabbani","Suhad Ali","Jean Jacques Lebrun"],"collection":[]},"attributes":{"deliveryPlatform":"oscar","template":"rebrand","cms":null,"copyright":{"creativeCommonsType":null,"openAccess":false},"environment":"live"},"journal":{"siteKey":"breast-cancer-research.biomedcentral.com","volume":"15","issue":"3","title":"Breast Cancer Research","type":"BioMed","journalID":13058,"section":[]},"category":{"pmc":{"primarySubject":"Biomedicine"},"contentType":"Research article","publishingSegment":"BioMed2"}},"session":{"authentication":{"authenticationID":[]}},"version":"1.0.0","page":{"category":{"pageType":"article"},"attributes":{"featureFlags":[],"environment":"live"}},"event":"dataLayerCreated"}];
    </script>

        

        
            <script>
                window.dataLayer.push({
                    cmpAndNewGtmFeatureFlag: true
                });
            </script>
        

        
        
            <script>
                window.dataLayer.push({
                    ga4MeasurementId: 'G-PJCTJWPV25',
                    ga360TrackingId: 'UA-54492316-9',
                    twitterId: 'o47a2',
                    ga4ServerUrl: 'https://collect.biomedcentral.com',
                    imprint: 'biomedcentral'
                });
            </script>
        
        

        
    <script>
        (function(w, d) {
            w.config = w.config || {};
            w.config.mustardcut = false;

            
            if (w.matchMedia && w.matchMedia('only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)').matches) {
                w.config.mustardcut = true;
                d.classList.add('js');
                d.classList.remove('grade-c');
            }
        })(window, document.documentElement);
    </script>



        
<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>

        
    <script class="js-entry">
        if (window.config.mustardcut) {
            (function(w, d) {
                
                
                
                    window.Component = {};
                    window.suppressShareButton = true;
                

                var currentScript = d.currentScript || d.head.querySelector('script.js-entry');

                
                function catchNoModuleSupport() {
                    var scriptEl = d.createElement('script');
                    return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)
                }

                var headScripts = [
                    {'src': '/static/js/polyfill-es5-bundle-95f6277fcf.js', 'async': false},
                    {'src': '/static/js/airbrake-es5-bundle-80569d2d62.js', 'async': false},
                ];

                var bodyScripts = [
                    {'src': '/static/js/app-es5-bundle-5306b345a4.js', 'async': false, 'module': false},
                    {'src': '/static/js/app-es6-bundle-8425be8e90.js', 'async': false, 'module': true}
                    
                    
                        , {'src': '/static/js/global-article-es5-bundle-d18afc649a.js', 'async': false, 'module': false},
                        {'src': '/static/js/global-article-es6-bundle-cef3b249aa.js', 'async': false, 'module': true}
                    
                ];

                function createScript(script) {
                    var scriptEl = d.createElement('script');
                    scriptEl.src = script.src;
                    scriptEl.async = script.async;
                    if (script.module === true) {
                        scriptEl.type = "module";
                        if (catchNoModuleSupport()) {
                            scriptEl.src = '';
                        }
                    } else if (script.module === false) {
                        scriptEl.setAttribute('nomodule', true)
                    }
                    if (script.charset) {
                        scriptEl.setAttribute('charset', script.charset);
                    }

                    return scriptEl;
                }

                for (var i = 0; i < headScripts.length; ++i) {
                    var scriptEl = createScript(headScripts[i]);
                    currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);
                }

                d.addEventListener('DOMContentLoaded', function() {
                    for (var i = 0; i < bodyScripts.length; ++i) {
                        var scriptEl = createScript(bodyScripts[i]);
                        d.body.appendChild(scriptEl);
                    }
                });

                // Webfont repeat view
                var config = w.config;
                if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {
                    d.documentElement.className += ' webfonts-loaded';
                }
            })(window, document);
        }
    </script>




        
            
            
                <script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                
                    j.src = 'https://collect.biomedcentral.com/gtm.js?id=' + i + dl;
                
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>

            
            
        

        <script>
    (function (w, d, t) {
        function cc() {
            var h = w.location.hostname;
            var e = d.createElement(t),
            s = d.getElementsByTagName(t)[0];

            if (h.indexOf('springer.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-17-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else if (h.indexOf('biomedcentral.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-15-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else if (h.indexOf('springeropen.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-16-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-444fb65518.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window, document, 'script');
</script>


        
    
        
    


        
    
    <link rel="canonical" href="//breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3441"/>
    

        
        
        
        <meta property="og:url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3441">
        <meta property="og:type" content="article">
        <meta property="og:site_name" content="BioMed Central">
        <meta property="og:title" content="Cyclin D1 cooperates with p21 to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion - Breast Cancer Research">
        <meta property="og:description" content="Introduction Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGFÎ²) in breast cancer progression. Methods Cyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion. Results We found TGFÎ² to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGFÎ²-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGFÎ²-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGFÎ² promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the in vivo studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21. Conclusions Thus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGFÎ²-mediated tumor growth initiation and local tumor cell invasion, both in vitro and in vivo.">
        <meta property="og:image" content="https://media.springernature.com/w200/springer-static/cover/journal/13058.jpg">
    
        

        
    <script type="application/ld+json">{"mainEntity":{"headline":"Cyclin D1 cooperates with p21 to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion","description":"Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGFÎ²) in breast cancer progression. Cyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion. We found TGFÎ² to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGFÎ²-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGFÎ²-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGFÎ² promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the in vivo studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21. Thus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGFÎ²-mediated tumor growth initiation and local tumor cell invasion, both in vitro and in vivo.","datePublished":"2013-06-20","dateModified":"2013-06-20","pageStart":"1","pageEnd":"14","sameAs":"https://doi.org/10.1186/bcr3441","keywords":"Cancer Research,Oncology,Surgical Oncology","image":"https://static-content.springer.com/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig1_HTML.jpg","isPartOf":{"name":"Breast Cancer Research","issn":["1465-542X"],"volumeNumber":"15","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Dai, Meiou","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Al-Odaini, Amal A","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Dammam, Ministry of Higher Education","address":{"name":"University of Dammam, Ministry of Higher Education, Kragujevac, Saudi Arabia","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Fils-AimÃ©, NadÃ¨ge","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Villatoro, Manuel A","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Guo, Jimin","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Arakelian, Ani","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Rabbani, Shafaat A","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ali, Suhad","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Lebrun, Jean Jacques","affiliation":[{"name":"McGill University Health Center, Royal Victoria Hospital","address":{"name":"Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada","@type":"PostalAddress"},"@type":"Organization"}],"email":"jj.lebrun@mcgill.ca","@type":"Person"}],"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>

        
    </head>

    <body class="journal journal-fulltext"
    
          >
        
    
        
            <!-- Google Tag Manager (noscript) -->
            <noscript>
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                        height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
            <!-- End Google Tag Manager (noscript) -->
        
    

        <div class="u-visually-hidden" aria-hidden="true">
    
    <?xml version="1.0" encoding="UTF-8"?><!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"/></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"/></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"/></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"/></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"/></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"/></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"/></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"/></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"/></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"/></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"/></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"/></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"/></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"/></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"/></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"/></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"/></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"/></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"/></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"/></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"/></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"/></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"/></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m1.00087166 7h5.99912834v-5.99912834c0-.55276615.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v5.99912834h5.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-5.9991283v5.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-5.9991283h-5.99912834c-.55276615 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"/></symbol><symbol id="icon-search"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"/></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"/></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"/></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"/></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"/></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"/></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"/></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"/></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"/></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"/></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"/></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/><path d="M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213
	c-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354
	L483.025,280.48L483.025,280.48z"/></symbol><symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"><g><path d="M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502
		c-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71
		c0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361
		c0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656
		c-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883
		c-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215
		c4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z"/></g><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/></symbol><symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z"/><g><path d="M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588
		c2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63
		c-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021
		c0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027
		c-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493
		C485.697,280.594,484.689,279.911,483.782,279.63"/><path d="M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72
		c0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0
		c-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833
		"/><path d="M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621
		c0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0
		c-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276"/><path d="M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389
		c0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301
		c-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393
		C477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396
		c-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437"/></g></symbol><symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"/></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 3)"/></symbol><symbol id="icon-download-rounded"><path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"/></symbol><symbol id="icon-ext-link" viewBox="0 0 16 16"><path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"/><path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"/><path d="M9.7 0L16 6.2V0z"/></symbol><symbol id="icon-remove" viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"/><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"/></symbol><symbol id="icon-rss" viewBox="0 0 18 18"><path d="m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z" fill-rule="evenodd"/></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/></symbol><symbol id="icon-springer-collections" viewBox="3 3 32 32"><path fill-rule="evenodd" d="M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z"/></symbol><symbol id="icon-springer-download" viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"/></symbol><symbol id="icon-springer-info" viewBox="0 0 24 24"><!--Generator: Sketch 63.1 (92452) - https://sketch.com--><g id="V&amp;I" stroke="none" stroke-width="1" fill-rule="evenodd"><g id="info" fill-rule="nonzero"><path d="M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z" id="Combined-Shape"/></g></g></symbol><symbol id="icon-springer-tick-circle" viewBox="0 0 24 24"><g id="Page-1" stroke="none" stroke-width="1" fill-rule="evenodd"><g id="springer-tick-circle" fill-rule="nonzero"><path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z" id="path-1"/></g></g></symbol><symbol id="icon-updates" viewBox="0 0 18 18"><g fill-rule="nonzero"><path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"/><path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"/></g></symbol></svg>
</div>


        

        

    <div class="u-vh-full">
        <a class="c-skip-link" href="#main-content">Skip to main content</a>
        
            
    
        <div class="u-hide u-show-following-ad"></div>
    
    <aside class="adsbox c-ad c-ad--728x90" data-component-mpu>
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-LB1"
                data-ad-type="LB1"
                data-pa11y-ignore
                data-gpt
                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"
                data-gpt-sizes="728x90,970x90"
                data-gpt-targeting="pos=LB1;doi=10.1186/bcr3441;type=article;kwrd=Cyclin D1,p21Cip1,Transforming growth factor beta (TGFÎ²),Breast cancer,Migration,Invasion;pmc=B11001,H33160,H59150;"
            >
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/bcr3441&amp;type=article&amp;kwrd=Cyclin D1,p21Cip1,Transforming growth factor beta (TGFÎ²),Breast cancer,Migration,Invasion&amp;pmc=B11001,H33160,H59150&amp;">
                        <img data-test="gpt-advert-fallback-img"
                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/bcr3441&amp;type=article&amp;kwrd=Cyclin D1,p21Cip1,Transforming growth factor beta (TGFÎ²),Breast cancer,Migration,Invasion&amp;pmc=B11001,H33160,H59150&amp;"
                            alt="Advertisement"
                            width="728"
                            height="90">
                    </a>
                </noscript>
            </div>
        </div>
    </aside>

        
        

         
    
        <div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"></div>
    
    
        <div id="top" class="u-position-relative">
    <header class="c-header" data-test="publisher-header">
        <div class="c-header__container">
            <div class="c-header__brand u-mr-48" itemscope itemtype="http://schema.org/Organization" data-test="navbar-logo-header">
                <div class="c-logo">
    <a href="https://www.biomedcentral.com" itemprop="url">
        <img alt="BMC" itemprop="logo" width="76" height="18" role="img" src=/static/images/bmc/logos/logo-bmc-white-aj-be532aa3f0.svg>
        <div class="c-logo__strapline">
            <img alt="Part of Springer Nature" width="173" height="16" role="img" src=/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg>
        </div>
    </a>
</div>

            </div>
            <div class="c-header__navigation">
                <button
                    type="button"
                    class="c-header__link u-button-reset u-mr-24"
                    data-expander
                    data-expander-target="#publisher-header-search"
                    data-expander-autofocus="firstTabbable"
                    data-test="header-search-button"
                    aria-controls="publisher-header-search"
                    aria-expanded="false">
                    <span class="u-display-flex u-align-items-center">
                        <span class="u-text-sm">Search</span>
                        <svg class="u-icon u-flex-static u-ml-8" aria-hidden="true" focusable="false">
                            <use xlink:href="#global-icon-search"></use>
                        </svg>
                    </span>
                </button>
                <nav>
                    <ul class="c-header__menu" data-enhanced-menu data-test="publisher-navigation">
                        
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/journals">
                                        Explore journals
                                    </a>
                                </li>
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/getpublished">
                                        Get published
                                    </a>
                                </li>
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/about">
                                        About BMC
                                    </a>
                                </li>
                            
                        
                        <li class="c-header__item">
                            <a data-enhanced-account
                               class="c-header__link"
                               href="https://www.biomedcentral.com/account"
                               data-test="login-link">
                                My account
                            </a>
                        </li>
                    </ul>
                </nav>
            </div>
        </div>
    </header>
    <div class="c-popup-search u-js-hide" id="publisher-header-search">
        <div class="u-container">
            <div class="c-popup-search__container">
                <div class="ctx-search">
    <form role="search" class="c-form-field" method="GET" action="//www.biomedcentral.com/search" data-track="submit"
        data-track-category="Search and Results" data-track-action="Submit search" data-dynamic-track-label data-track-label="" data-test="global-search">
        <label for="publisherSearch" class="c-form-field__label">Search all BMC articles</label>
        <div class="u-display-flex">
            <input id="publisherSearch" class="c-form-field__input" data-search-input autocomplete="off" role="textbox" data-test="search-input" name="query" type="text" value=""/>
            <div>
                <button class="u-button" type="submit" data-test="search-submit-button">
    <span class="u-visually-hidden">Search</span>
    <svg class="u-icon u-flex-static" width="16" height="16" aria-hidden="true" focusable="false">
        <use xlink:href="#global-icon-search"></use>
    </svg>
</button>


            </div>
        </div>
        <input type="hidden" name="searchType" value="publisherSearch"/>
    </form>
</div>

            </div>
        </div>
    </div>
</div>

    

        
            <header class="c-journal-header c-journal-header--breast-cancer-research ctx-journal-header">
                <div class="u-container">
                    <div class="c-journal-header__inner ">
                        
                        <div class="c-journal-title" id="journalTitle">
                            <a href="/">
    
        
    
    <span class="c-journal-title__text ">Breast Cancer Research</span>
    
</a>
                        </div>
                        
                    </div>
                </div>
                <div class="c-navbar">
                    <div class="c-navbar__container">
                        
                            <div class="c-navbar__content">
                                <nav class="c-navbar__nav">
                                    <ul class="c-navbar__nav c-navbar__nav--journal" role="menu" data-test="site-navigation">
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="Home" data-track-action="Clicked journal navigation link" href='/'>Home</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="About" data-track-action="Clicked journal navigation link" href='/about'>About</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link c-navbar__link--is-shown" data-track="click" data-track-category="Articles" data-track-action="Clicked journal navigation link" href='/articles'>Articles</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href='/submission-guidelines'>Submission Guidelines</a>
                                            </li>
                                        
                                    </ul>
                                </nav>
                            </div>
                        
                    </div>
                </div>
                <div class="c-journal-header__identity c-journal-header__identity--midnight-purple">
                    
                </div>
            </header>
            
        

        <div class="u-container u-mt-32 u-mb-32 u-clearfix" id="main-content" data-component="article-container">

            <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
                
    <div class="c-pdf-download u-clear-both">
        <a href="//breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3441.pdf" class="c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>

                <article lang="en">
                    <div class="c-article-header">
                        
    


                        <ul class="c-article-identifiers" data-test="article-identifier">
                            
    
        <li class="c-article-identifiers__item" data-test="article-category">Research article</li>
    
    
        <li class="c-article-identifiers__item">
            <span class="c-article-identifiers__open" data-test="open-access">Open Access</span>
        </li>
    
    

                            <li class="c-article-identifiers__item"><a href="#article-info" data-track="click" data-track-action="publication date" data-track-label="link">Published: <time datetime="2013-06-20">20 June 2013</time></a></li>
                        </ul>

                        <h1 class="c-article-title" data-test="article-title" data-article-title="">Cyclin D1 cooperates with p21 to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion</h1>
                        <ul class="c-article-author-list js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Meiou-Dai" data-author-popup="auth-Meiou-Dai">Meiou Dai</a><sup class="u-js-hide"><a href="#Aff7">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Amal_A-Al_Odaini" data-author-popup="auth-Amal_A-Al_Odaini">Amal A Al-Odaini</a><sup class="u-js-hide"><a href="#Aff7">1</a>,<a href="#Aff8">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Nad_ge-Fils_Aim_" data-author-popup="auth-Nad_ge-Fils_Aim_">NadÃ¨ge Fils-AimÃ©</a><sup class="u-js-hide"><a href="#Aff7">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Manuel_A-Villatoro" data-author-popup="auth-Manuel_A-Villatoro">Manuel A Villatoro</a><sup class="u-js-hide"><a href="#Aff7">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Jimin-Guo" data-author-popup="auth-Jimin-Guo">Jimin Guo</a><sup class="u-js-hide"><a href="#Aff7">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Ani-Arakelian" data-author-popup="auth-Ani-Arakelian">Ani Arakelian</a><sup class="u-js-hide"><a href="#Aff9">3</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Shafaat_A-Rabbani" data-author-popup="auth-Shafaat_A-Rabbani">Shafaat A Rabbani</a><sup class="u-js-hide"><a href="#Aff9">3</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Suhad-Ali" data-author-popup="auth-Suhad-Ali">Suhad Ali</a><sup class="u-js-hide"><a href="#Aff7">1</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Jean_Jacques-Lebrun" data-author-popup="auth-Jean_Jacques-Lebrun" data-corresp-id="c1">Jean Jacques Lebrun<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-email"></use></svg></a><sup class="u-js-hide"><a href="#Aff7">1</a></sup>Â </li></ul>
                        <p class="c-article-info-details" data-container-section="info">
                            
    <a data-test="journal-link" href="/"><i data-test="journal-title">Breast Cancer Research</i></a>

                            <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>Â 15</b>, ArticleÂ number:Â <span data-test="article-number">3246</span> (<span data-test="article-publication-year">2013</span>)
            <a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                        </p>
                        
    <div class="c-article-metrics-bar__wrapper u-clear-both">
        <ul class="c-article-metrics-bar u-list-reset">
            
                <li class=" c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">11k <span class="c-article-metrics-bar__label">Accesses</span></p>
                </li>
            
            
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">74 <span class="c-article-metrics-bar__label">Citations</span></p>
                </li>
            
            
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">1 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                    </li>
                
            
            <li class="c-article-metrics-bar__item">
                <p class="c-article-metrics-bar__details"><a href="/articles/10.1186/bcr3441/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
            </li>
        </ul>
    </div>

                        
                        
    
        <div class="u-mb-8 c-status-message c-status-message--boxed c-status-message--info">
            <span class="c-status-message__icon">
                <svg class="u-icon" width="18" height="18" aria-hidden="true" focusable="false">
                    <use xlink:href="#icon-info"></use>
                </svg>
            </span>
            
                
                    <p>An <a href="/articles/10.1186/s13058-017-0831-8" class="relation-link" data-track="click" data-track-action="view linked article" data-track-label="link">Erratum</a> to this article was published on 28 March 2017</p>
                
            
        </div>
    

    

                        
                    </div>

                    <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Introduction</h3><p>Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also lead to tumor progression and invasiveness of the cancer. In particular, cyclin D1 and p21 are often over-expressed in human cancers, correlating with high tumor grade, poor prognosis and increased metastasis. This prompted us to investigate the role of the cyclin D1/p21 signaling axis downstream of transforming growth factor beta (TGFÎ²) in breast cancer progression.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Methods</h3><p>Cyclins mRNA and protein expressions were assessed by quantitative real-time PCR and Western blot in triple negative breast cancer cell lines. Co-localization and interaction between cyclin D1 and p21 were performed by immunocytochemistry and co-immunoprecipitation, respectively. Cell migration was assessed by wound healing and quantitative time-lapse imaging assays. In addition, the effects of cyclin D1 on cellular structure and actin organization were examined by staining with F-actin marker phalloidin and mesenchymal intermediate filament vimentin. Finally, a mammary fat pad xenograft mouse model was used to assess mammary tumor growth and local invasion.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Results</h3><p>We found TGFÎ² to specifically up-regulate the expression of cyclin D1 in triple negative breast cancer cells. Induction of cyclin D1 is also required for TGFÎ²-mediated cell migration. Suppression of cyclin D1 expression not only resulted in a rounded and epithelial-like phenotype, but also prevented TGFÎ²-induced vimentin and F-actin co-localization at the cell edge as well as invadopodia formation. Furthermore, TGFÎ² promoted the nuclear co-localization and physical interaction between cyclin D1 and p21. The co-expression of cyclin D1 and p21 proteins are required for the initial steps of tumor development, as double knockdown of these two molecules prevented primary tumor formation in a Xenograft mouse model. Moreover, the <i>in vivo</i> studies indicated that locally advanced features of the invasive tumors, including skeletal muscle, mammary fat pad and lymphovascular invasion, as well as ulcerated skin, were attenuated in the absence of cyclin D1 and p21.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Conclusions</h3><p>Thus, our findings highlight the cyclin D1/p21 signaling axis as a critical regulator of TGFÎ²-mediated tumor growth initiation and local tumor cell invasion, both <i>in vitro</i> and <i>in vivo</i>.</p></div></div></section>
                    
    


                    <section data-title="Introduction"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Introduction</h2><div class="c-article-section__content" id="Sec1-content"><p>Metastatic cancer is a largely incurable disease and responsible for 90% of human cancer deaths [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Gupta GP, Massague J: Cancer metastasis: building a framework.&#xA;                                    Cell 2006, 127:679â695." href="/articles/10.1186/bcr3441#ref-CR1" id="ref-link-section-d169286048e655">1</a>]. To develop metastasis in a distant organ, cancer cells must initially disseminate from the primary tumor and invade through the surrounding basement membrane and stroma into lymphatic or blood vessels, followed by survival, extravasation and re-implantation at a secondary site [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.&#xA;                                    Nat Rev Cancer 2003, 3:453â458." href="/articles/10.1186/bcr3441#ref-CR2" id="ref-link-section-d169286048e658">2</a>]. As cancer cell motility and invasiveness are critical features in the initial development of metastasis, many molecules involved in these processes are becoming attractive therapeutic targets [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Mack GS, Marshall A: Lost in migration.&#xA;                                    Nat Biotechnol 2010, 28:214â229." href="/articles/10.1186/bcr3441#ref-CR3" id="ref-link-section-d169286048e661">3</a>]. Understanding the molecular mechanisms that govern these early processes may provide insightful strategies for the prevention of cancer progression and metastasis.</p><p>The transforming growth factor beta (TGFÎ²) superfamily is comprised of many members, including activins, anti-MÃ¼llerian hormone, bone morphogenetic proteins, growth and differentiation factors, inhibins and TGFÎ²s [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus.&#xA;                                    Cell 2003, 113:685â700." href="/articles/10.1186/bcr3441#ref-CR4" id="ref-link-section-d169286048e667">4</a>]. Among these family members, TGFÎ² ligands and its receptors are widely expressed in all tissues and the regulatory role played by these growth factors is of central importance to human cancer development and progression. TGFÎ² can be released from storage sites in the extracellular matix (ECM) and bone, as well as secreted in a paracrine and autocrine manner by platelet, myeloid, mesenchymal and cancer cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Bierie B, Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.&#xA;                                    Nat Rev Cancer 2006, 6:506â520." href="/articles/10.1186/bcr3441#ref-CR5" id="ref-link-section-d169286048e670">5</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Labelle M, Begum S, Hynes RO: Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.&#xA;                                    Cancer Cell 2011, 20:576â590." href="/articles/10.1186/bcr3441#ref-CR7" id="ref-link-section-d169286048e673">7</a>]. The increasing amount of TGFÎ²1 is correlated with a high incidence of distant metastasis as TGFÎ² acts on the tumor cells and the surrounding stroma to promote epithelial to mesenchymal transition (EMT), ECM degradation, cell migration, cell invasion, angiogenesis, immunosuppression and modification of the tumor microenvironment [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Dumont N, Arteaga CL: Targeting the TGF beta signaling network in human neoplasia.&#xA;                                    Cancer Cell 2003, 3:531â536." href="/articles/10.1186/bcr3441#ref-CR8" id="ref-link-section-d169286048e676">8</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Wakefield LM, Roberts AB: TGF-beta signaling: positive and negative effects on tumorigenesis.&#xA;                                    Curr Opin Genet Dev 2002, 12:22â29." href="/articles/10.1186/bcr3441#ref-CR11" id="ref-link-section-d169286048e679">11</a>]. Intravital imaging of live tumor-bearing nude mice demonstrated that active TGFÎ² signaling is heterogeneously distributed in a minority of cancer cells within primary mammary tumors [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E: Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility.&#xA;                                    Nat Cell Biol 2009, 11:1287â1296." href="/articles/10.1186/bcr3441#ref-CR12" id="ref-link-section-d169286048e683">12</a>]. The activation of TGFÎ² signaling promotes single tumor cell migration and metastatic spread into blood vessels and lymph nodes. However, not all cells with active TGFÎ² signaling are migratory, suggesting differential TGFÎ² signaling events and specific downstream targets are required for this process.</p><p>TGFÎ² signal transduction begins with ligand binding to the TGFÎ² type II receptor, which recruits and activates the type I receptor. The activated type I receptor then phosphorylates intracellular mediators known as receptor-regulated Smads (R-Smads), Smad2 and Smad3. This phosphorylation event allows for subsequent heterotrimerization of two phosphorylated R-Smad subunits with one common partner, Smad4 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP, Lin K: The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization.&#xA;                                    Nat Struct Biol 2001, 8:248â253." href="/articles/10.1186/bcr3441#ref-CR13" id="ref-link-section-d169286048e689">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, de Caestecker M, Lin K: Structural basis of heteromeric smad protein assembly in TGF-beta signaling.&#xA;                                    Mol Cell 2004, 15:813â823." href="/articles/10.1186/bcr3441#ref-CR14" id="ref-link-section-d169286048e692">14</a>]. The Smad heterotrimer then translocates to the nucleus where it can bind DNA, but with a very low affinity [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Shi Y, Wang YF, Jayaraman L, Yang H, Massague J, Pavletich NP: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling.&#xA;                                    Cell 1998, 94:585â594." href="/articles/10.1186/bcr3441#ref-CR15" id="ref-link-section-d169286048e695">15</a>]. In order to achieve high affinity binding, the Smads associate with various DNA binding partners [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Massague J, Wotton D: Transcriptional control by the TGF-beta/Smad signaling system.&#xA;                                    EMBO J 2000, 19:1745â1754." href="/articles/10.1186/bcr3441#ref-CR16" id="ref-link-section-d169286048e698">16</a>]. It is thought that these partner proteins, which act as co-activators or co-repressors, are functionally expressed in different cell types, thus providing a basis for tissue and cell type-specific functions for TGFÎ² ligands [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Massague J: TGFbeta signalling in context.&#xA;                                    Nat Rev Mol Cell Biol 2012, 13:616â630." href="/articles/10.1186/bcr3441#ref-CR17" id="ref-link-section-d169286048e701">17</a>].</p><p>Perturbations in the regulation of the cell cycle machinery often occur in human cancers, resulting in an imbalance between cell growth and cell death [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Massague J: G1 cell-cycle control and cancer.&#xA;                                    Nature 2004, 432:298â306." href="/articles/10.1186/bcr3441#ref-CR18" id="ref-link-section-d169286048e707">18</a>]. In addition, several reports have proposed that deregulation of cell cycle regulators results not only in proliferative advantages, but also in increased tumor progression and aggressiveness traits [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Besson A, Dowdy SF, Roberts JM: CDK inhibitors: cell cycle regulators and beyond.&#xA;                                    Dev Cell 2008, 14:159â169." href="/articles/10.1186/bcr3441#ref-CR19" id="ref-link-section-d169286048e710">19</a>]. Cell cycle progression is primarily mediated through interactions between the different cyclins with their respective cyclin-dependent kinases (CDKs). Among the different cyclins, cyclin D1 and cyclin E are associated with the G1-S phase transition [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Sherr CJ: G1 phase progression: cycling on cue.&#xA;                                    Cell 1994, 79:551â555." href="/articles/10.1186/bcr3441#ref-CR20" id="ref-link-section-d169286048e713">20</a>]. Cyclin D1 interacts with CDK4 and 6, while cyclin E interacts more specifically with CDK2 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G: CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.&#xA;                                    Oncogene 1994, 9:71â79." href="/articles/10.1186/bcr3441#ref-CR21" id="ref-link-section-d169286048e716">21</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ: Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.&#xA;                                    Cell 1992, 71:323â334." href="/articles/10.1186/bcr3441#ref-CR25" id="ref-link-section-d169286048e719">25</a>]. The activity of the cyclin-CDK complexes is regulated by two classes of small proteins referred to as cyclin-dependent kinases inhibitors (CDKIs). The INK4 family, which includes p15INK4, p16INK4A, p18INK4C and p19INK4D, specifically binds to CDK4 and 6, thereby preventing their association with the D-type cyclins [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest [see comments].&#xA;                                    Nature 1994, 371:257â261." href="/articles/10.1186/bcr3441#ref-CR26" id="ref-link-section-d169286048e723">26</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.&#xA;                                    Mol Cell Biol 1995, 15:2672â2681." href="/articles/10.1186/bcr3441#ref-CR29" id="ref-link-section-d169286048e726">29</a>]. The KIP family includes p21CIP1/WAF1 (p21), p27KIP1 and p57KIP2 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.&#xA;                                    Cell 1993, 75:805â816." href="/articles/10.1186/bcr3441#ref-CR30" id="ref-link-section-d169286048e729">30</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.&#xA;                                    Genes Dev 1995, 9:639â649." href="/articles/10.1186/bcr3441#ref-CR35" id="ref-link-section-d169286048e732">35</a>]. While the KIP family members are usually associated with cyclin E-CDK and cyclin A-CDK complexes, many reports indicated that they also interact with cyclin D-CDK complexes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.&#xA;                                    Cell 1993, 75:805â816." href="/articles/10.1186/bcr3441#ref-CR30" id="ref-link-section-d169286048e735">30</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression.&#xA;                                    Genes Dev 1999, 13:1501â1512." href="/articles/10.1186/bcr3441#ref-CR36" id="ref-link-section-d169286048e738">36</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Yu ZK, Gervais JL, Zhang H: Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.&#xA;                                    Proc Natl Acad Sci USA 1998, 95:11324â11329." href="/articles/10.1186/bcr3441#ref-CR38" id="ref-link-section-d169286048e742">38</a>].</p><p>Many of these cell cycle regulators are primary targets of TGFÎ² signaling in human cancers [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Massague J: TGFbeta in Cancer.&#xA;                                    Cell 2008, 134:215â230." href="/articles/10.1186/bcr3441#ref-CR39" id="ref-link-section-d169286048e749">39</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Seoane J, Le HV, Shen L, Anderson SA, Massague J: Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.&#xA;                                    Cell 2004, 117:211â223." href="/articles/10.1186/bcr3441#ref-CR41" id="ref-link-section-d169286048e752">41</a>]. Interestingly, some of these cell cycle regulators, in particular cyclin D1 and p21, are often over-expressed in many human cancers and their levels are correlated with high tumor grade, poor prognosis, and increased metastasis in subsets of carcinomas such as breast, prostate, cervical carcinomas and lymphomas [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Abbas T, Dutta A: p21 in cancer: intricate networks and multiple activities.&#xA;                                    Nat Rev Cancer 2009, 9:400â414." href="/articles/10.1186/bcr3441#ref-CR42" id="ref-link-section-d169286048e755">42</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL: Cyclin D as a therapeutic target in cancer.&#xA;                                    Nat Rev Cancer 2011, 11:558â572." href="/articles/10.1186/bcr3441#ref-CR43" id="ref-link-section-d169286048e758">43</a>]. We previously demonstrated that p21 is a transcriptional co-regulator of Smad that mediates TGFÎ²-induced breast cancer cell migration and invasion in metastatic breast cancer cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e761">44</a>]. This prompted us to explore the roles of other cell cycle regulators in promoting tumor progression in breast cancer, aside from their well-established functions in cell cycle regulation. Thus, we investigated the effects of cyclins, in particular cyclin D1, downstream of TGFÎ²-mediated tumor progression. Indeed, several studies have supported the notion that the oncogenic effects of cyclin D1 may not be simply due to enhanced tumor cell growth or proliferation. These include reports showing a lack of correlation between cell proliferation and cyclin D1 expression in several large cohorts of 779 breast cancer patients [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT: Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.&#xA;                                    Clin Cancer Res 2009, 15:3654â3662." href="/articles/10.1186/bcr3441#ref-CR45" id="ref-link-section-d169286048e765">45</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, Knudsen ES: RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.&#xA;                                    Cell Cycle 2010, 9:4153â4163." href="/articles/10.1186/bcr3441#ref-CR46" id="ref-link-section-d169286048e768">46</a>] and the fact that elevated cyclin D1 expression is associated with a high incidence of metastasis and poor survival outcome [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C: Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.&#xA;                                    Clin Cancer Res 2000, 6:1891â1895." href="/articles/10.1186/bcr3441#ref-CR47" id="ref-link-section-d169286048e771">47</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.&#xA;                                    Cancer Res 1994, 54:4813â4817." href="/articles/10.1186/bcr3441#ref-CR48" id="ref-link-section-d169286048e774">48</a>], suggesting that cyclin D1 may play a role in promoting invasiveness of established tumors.</p><p>In this study, we found that TGFÎ² induced mRNA and protein expression of cyclin D1 in breast cancer cells with a highly migratory phenotype. Moreover, we found TGFÎ² to induce complex formation and nuclear co-localization of cyclin D1 and p21, indicating that these two proteins may cooperate to mediate TGFÎ² functions in aggressive human breast cancer cells. Furthermore, using gene silencing approaches, our results indicate that TGFÎ²-mediated cyclin D1 expression is a prerequisite for TGFÎ²-induced breast cancer cell migration. Orthotopic injection of cyclin D1/p21 null human breast cancer cells in nude mice considerably reduced mammary tumor growth <i>in vivo</i>, compared to animals injected with parental tumor cells. Moreover, we found that following fat pad transplantation, parental breast cancer cells invaded into the surrounding mammary tissues, while these effects were blocked when cyclin D1 and p21 gene expression were silenced. Collectively, these data indicate that TGFÎ²-mediated cyclin D1 and p21 gene expression leads to increased breast cancer migration and invasion <i>in vitro</i> and that blocking expression of these two cell cycle regulators in aggressive human breast tumors significantly reduced both tumor formation and local tumor invasion into the surrounding tissues <i>in vivo</i>.</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Methods</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">Cell culture and transfection</h3><p>Human breast cancer cell lines MDA-MB-231 (hereafter referred to as MDA) and SCP2 (provided by Dr. Joan MassaguÃ©) were cultured in DMEM containing 10% fetal bovine serum (FBS) and 2 mM L-glutamine. SUM149PT, SUM159PT and SUM229PE (provided by Dr. Stephen P. Ethier) were plated in F-12 HAM'S nutrient mixture (HyClone Laboratories, Inc., Logan, UT, USA) containing 5% FBS, 5 Âµg/ml insulin (Sigma-Aldrich, St. Louis, MO, USA), and 1 Âµg/ml hydrocortisone (Sigma). SUM1315MO<sub>2</sub> were cultured in F-12 HAM'S nutrient mixture (HyClone) containing 5% FBS, 5 Âµg/ml insulin (Sigma), and 10 ng/ml epidermal growth factor (EGF) (Sigma). All cell lines were grown at 37Â°C in 5% CO<sub>2</sub>. Before stimulation with 5 ng/ml TGFÎ²1 (PeproTech, Rocky Hill, NJ, USA), cells were serum-starved overnight. For cell transfection, flag-tagged p21 cDNA (Addgene plasmid 16240), HA-tagged cyclin D1 cDNA (Addgene plasmid 11181), scrambled and cyclin D1 siRNAs (Sigma) were transfected using Lipofectamineâ¢ 2000 (Invitrogen, Carlsbad, CA, USA), according to the manufacturers' protocols.</p><h3 class="c-article__sub-heading" id="Sec4">Western blot analysis and immunoprecipitation</h3><p>Protein extraction buffer containing 10 mM Tris-HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 1 mM sodium orthovanadate, 1% Triton X-100 and protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 Âµg/ml leupeptin hydrochloride, 10 Âµg/ml aprotinin and 10 Âµg/ml pepstatin A) were freshly prepared and kept at 4Â°C before cell lysis. After cell lysates were centrifuged at 14,000 rpm for 15 minutes at 4Â°C, the concentration of total protein was quantified using a BCA protein assay kit (Thermo Scientific, Rockford, IL, USA). Cell lysates were boiled with 6Ã sodium dodecyl sulfate (SDS) Laemmli sample buffer for five minutes and subjected to immunoblot using mouse anti-p21 and rabbit anti-cyclin D1 antibodies (1:1,000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA). p21 and cyclin D1 were immunoprecipitated overnight at 4Â°C using their respective antibodies and followed by the addition of protein G-Sepharose beads (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) for one hour at 4Â°C. The immunocomplexes were washed four times with cold lysis buffer and then subjected to Western blot.</p><h3 class="c-article__sub-heading" id="Sec5">Real-Time PCR</h3><p>TRIzol reagent (Invitrogen) was used to extract total RNA and reverse transcription of total RNA was carried out using M-MLV reverse transcriptase and random primers (Invitrogen) according to the manufacturer's instructions. SsoFastâ¢EvaGreenÃ Supermix (Bio-Rad, Hercules, CA, USA) was used for amplification of the cyclin D1 mRNA in a Rotor Gene 6000 PCR detection system (MBI Lab Equipment, Montreal Biotech Inc., Kirkland, QC, Canada). The conditions for PCR were as follows: 95Â°C for 30 s, 40 cycles (95Â°C for 5 s and 59Â°C for 20 s). The primer sequences were as follows: cyclin D1 forward primer, AGCTGTGCATCTACACCGAC; reverse primer, ACTCCAGCAGGGCTTCGATCTG; <i>GAPDH</i> forward primer, GCCTCAAGATCATCAGCAATGCCT; reverse primer, TGTGGTCATGAGTCCTTCCACGAT.</p><h3 class="c-article__sub-heading" id="Sec6">Kinetic cell migration assay</h3><p>Cell migration was performed as previously described [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e831">44</a>]. Briefly, 50,000 cells per well were cultured in Essen ImageLock 96-well plates (Essen Bioscience, Ann Arbor, MI, USA). The confluent cell layers were scratched to generate a wound using the Essen Wound maker. Cells were then treated in the presence or the absence of 5 ng/ml of TGFÎ²1. The images/videos of the wound were automatically taken at the exact same location using the IncuCyteâ¢software (Essen Bioscience). Wound width, wound confluence or relative wound density were automatically measured by the IncuCyte software.</p><h3 class="c-article__sub-heading" id="Sec7">Transwell cell migration assay</h3><p>Transfected cell suspensions (40,000 cells/well) were seeded in 24-well Cell Culture Inserts (8-Âµm pore size; BD Biosciences, Mississauga, ON, Canada). After 24 hours incubation, the cells that migrated to the bottom of the membrane were fixed with 3.7% formaldehyde for 10 minutes and then labeled with the near-infrared fluorescence DNA binding dye DRAQ5 (2 Âµg/ml in PBS) at 37ÂºC for 5 minutes. The fluorescence intensity of migrated cells was measured at 700 nm in a near-infrared fluorescence imager (Odyssey CLX, LI-COR Biosciences - Biotechnology, Lincoln, NE, USA) using the Image Studio software (LI-COR Biosciences - Biotechnology).</p><h3 class="c-article__sub-heading" id="Sec8">Immunofluorescence microscopy</h3><p>For the invadopodia formation assay, cells were grown on top of eight-well chamber slides coated with 100 Âµl growth factor-reduced Matrigel. After TGFÎ² treatment for 24 hours, cells were fixed with 3.7% formaldehyde for 10 minutes, permeabilized in 0.1% Triton X-100 for 3 minutes, and blocked for 1 hour in 2% bovine serum albumin (BSA). Fixed cells were incubated with primary antibodies against p21, cyclin D1, F-actin and vimentin for one hour and followed by the secondary antibodies Alexa FluorÂ®568 goat anti-rabbit IgG and Alexa FluorÂ®488 goat anti-rabbit (1:800 dilution; Invitrogen) for one hour. Nuclei were stained with DAPI (Invitrogen). Confocal analysis was performed using a Zeiss LSM 510 Meta Axiovert confocal microscope (Carl Zeiss, Oberkochen, Baden-WÃ¼rttemberg, Germany) using the 63Ã objective.</p><h3 class="c-article__sub-heading" id="Sec9">Mammary fat pad injection of nude mice</h3><p>The animal study and SCP2 cells used in the mice model were approved by the McGill ethics committee (University Animal Care Committee, UACC) and all the experimental animal protocols were in accordance with the McGill University Animal Care. Four- to six-week old female Balb/c nude mice (Charles River Laboratories International, Wilmington, MA, USA) were used as a model for assessing mammary tumor formation and local invasion. An anesthetic cocktail of ketamine (50 mg/kg), xylazine (5 mg/kg) and acepromazine (1 mg/kg) was injected intramuscularly into mice (six per group). Fifty thousand parental SCP2 cells or p21 and cyclin D1 double knockdown SCP2 cells in 100 Î¼l of saline (20% Matrigel) were injected into the mice mammary fat pads using a 30-gauge needle. Tumor growth and size were measured using a caliper. At eight weeks post-injection, mice were sacrificed and mammary tumors with surrounding skin and tissues were fixed in 10% neutral-buffered formalin for one day. Sections of mammary tumor were embedded in Tissue-Tek O.C.T. (VWR International, Radnor, PA, USA) compound and 9 Âµm thick sections were stained with hematoxylin and eosin to assess local advanced features, including skeletal muscle, mammary fat pad, and lymphovascular invasion as well as skin ulceration. Images of the tumors were photographed by light microscope using 10Ã and 20Ã objectives.</p><p>For intratibia injections, parental and p21/cyclin D1-depleted SCP2 cells (2.0Ã 10<sup>6</sup>) were injected intramuscularly into the left tibia of two group mice (six per group). The mice were monitored weekly for tumor burden. Digital radiography of hind limbs of all animals was used to monitor the development of skeletal lesions at four, six and eight weeks post-injection in a MX-20 cabinet X-ray system (Faxitron X-ray Corp.). On week 8, radiographs of anesthetized mice were taken.</p><h3 class="c-article__sub-heading" id="Sec10">Statistical analyses</h3><p>The difference between groups was analyzed using Student's <i>t</i>-test, and *<i>P</i> &lt;0.05 was considered statistically significant.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec11-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec11">Results</h2><div class="c-article-section__content" id="Sec11-content"><h3 class="c-article__sub-heading" id="Sec12">TGFÎ² induces cyclin D1 expression in highly migratory breast cancer cells</h3><p>We have previously shown that TGFÎ²'s pro-migratory and invasive effects are mediated through the induction of p21 in highly migratory triple negative breast cancer cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e888">44</a>]. Due to the fact that p21 is a universal regulator of cyclin/CDKs, this prompted us to investigate whether additional cell cycle regulators downstream of TGFÎ² are involved in this process. Moreover, because multiple studies have suggested that the oncogenic effects of cyclins may not be simply due to enhanced tumor cell growth or proliferation but may also involve tumor promoting functions [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT: Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.&#xA;                                    Clin Cancer Res 2009, 15:3654â3662." href="/articles/10.1186/bcr3441#ref-CR45" id="ref-link-section-d169286048e891">45</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.&#xA;                                    Cancer Res 1994, 54:4813â4817." href="/articles/10.1186/bcr3441#ref-CR48" id="ref-link-section-d169286048e894">48</a>], we examined the effect of TGFÎ² on protein expression levels of cyclins A, B1, D1 and D2 in the human aggressive breast cancer cell lines MDA and its metastatic sub-progeny SCP2 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, MassaguÃ© J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.&#xA;                                    J Clin Invest 2005, 115:44â55." href="/articles/10.1186/bcr3441#ref-CR49" id="ref-link-section-d169286048e897">49</a>]. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig1">1A</a>, we found that TGFÎ² significantly increased cyclin D1 protein expression in a time-dependent fashion. The effect of TGFÎ² on cyclin D1 expression was specific, as protein levels of G1 and S phase regulators cyclin D2 and A remained unchanged in response to TGFÎ² stimulation. The M phase cyclin B1 was barely detectable. As a positive control, we measured the expression of p21, which we have previously shown to be potently induced by TGFÎ² in MDA cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e904">44</a>]. TGFÎ² induced the expression of p21 in a similar temporal expression pattern as cyclin D1 in these breast cancer cells. To assess whether TGFÎ² regulates cyclin D1 at the transcriptional level, we measured mRNA levels of cyclin D1 by quantitative PCR in SCP2 cells stimulated with TGFÎ² for 2, 6 and 24 hours. Induction of cyclin D1 mRNA by TGFÎ² was already detectable at 2 hours and was sustained for up to 24 hours (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig1">1B</a>). These results highlight cyclin D1 as a novel TGFÎ² downstream target gene in human breast cancer cells.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Figure 1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig1_HTML.jpg?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig1_HTML.jpg" alt="figure 1" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>
                                                    <b>TGFÎ² induces cyclin D1 expression in highly migratory breast cancer cells</b>. <b>(A)</b> MDA and SCP2 cells were stimulated with or without 5 ng/ml transforming growth factor beta (TGFÎ²) for the indicated times. Total cell lysates were subjected to immunoblot using cyclin D1, cyclin D2, cyclin A, cyclin B1, p21, p-Smad2, p-Smad3 and Î²-tubulin antibodies. Densitometry analysis of cyclin D1 protein expression was performed on four separate independent experiments (right panel). (<b>B and C)</b> cyclin D1 mRNA levels were measured by real-time PCR (error bars indicate SEM; <i>n</i> = 3 independent experiments) for the indicated cell lines.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
                                <p>To determine whether there was an association between TGFÎ² induction of cyclin D1 and TGFÎ²'s pro-migratory effect, we measured the mRNA level of cyclin D1 in a panel of triple negative breast cancer cell lines which are either insensitive (SUM1315) or responsive (SUM149 and SUM159) to TGFÎ²-mediated cell migration and invasion [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e944">44</a>]. Interestingly, TGFÎ² potently and persistently up-regulated cyclin D1 mRNA in the highly migratory cell lines SUM149 and SUM159, but not in the TGFÎ²-insensitive SUM1315 cell line (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig1">1C</a>). Together, these results indicate that TGFÎ²-induced cyclin D1 expression correlates with TGFÎ²-induced p21 gene expression and cell migration, thus, suggesting that cyclin D1 may be associated with p21 and participate in TGFÎ² tumor-promoting functions in breast cancer cells.</p><h3 class="c-article__sub-heading" id="Sec13">TGFÎ² promotes cyclin D1 nuclear accumulation and co-localization with p21</h3><p>The intracellular localization of cyclin D1 is important for its function and is, therefore, tightly regulated [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA: Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.&#xA;                                    Mol Cell 2006, 24:355â366." href="/articles/10.1186/bcr3441#ref-CR50" id="ref-link-section-d169286048e958">50</a>]. Constitutive accumulation of cyclin D1 in the nucleus has been shown to promote tumor transformation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Alt JR, Cleveland JL, Hannink M, Diehl JA: Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.&#xA;                                    Genes Dev 2000, 14:3102â3114." href="/articles/10.1186/bcr3441#ref-CR51" id="ref-link-section-d169286048e961">51</a>]. To determine whether TGFÎ² regulates cyclin D1 nuclear localization, we assessed the localization of cyclin D1 in MDA and SCP2 cells treated with or without TGFÎ² for 24 hours by confocal immunofluorescence microscopy. Cyclin D1 was predominantly found in the cytosol in unstimulated cells, whereas it appeared to be primarily retained within the nucleus after treatment with TGFÎ² (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig2">2A</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Figure 2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig2_HTML.jpg?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig2_HTML.jpg" alt="figure 2" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>
                                                    <b>TGFÎ² promotes cyclin D1 nuclear accumulation and co-localization with p21</b>. <b>(A)</b> MDA and SCP2 cells were treated with or without 5 ng/ml transforming growth factor beta (TGFÎ²) for 24 hours. Immunocytochemistry was performed using cyclin D1 (red) antibody and DAPI (blue). The scale bar is 10 Âµm. <b>(B)</b> MDA cells were immunostained using p21 (green) and cyclin D1 (red) antibodies. Co-localizaton (yellow) between p21 and cyclin D1 is represented by overlay. <b>(C)</b> MDA and SCP2 cells were treated with TGFÎ² for the indicated times. Cell lysates were analyzed by co-immunoprecipitation using an anti-cyclin D1 antibody. Immunoprecipitated cyclin D1 was subjected to Western blotting. <b>(D)</b> MDA, SUM149 and SUM159 cells were treated with TGFÎ². Cell lysates were immunoprecipitated using an anti-p21 antibody and analyzed by immunoblotting using anti-cyclin D1 and anti-p21 antibodies.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
                                <p>We have previously shown that TGFÎ² induces protein expression and nuclear localization of p21 in triple negative breast cancer cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e1004">44</a>]. The concurrent TGFÎ² effect on p21 and cyclin D1 prompted us to determine whether these molecules co-localize within the nucleus in response to TGFÎ². As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig2">2B</a>, TGFÎ² facilitates nuclear co-localization of cyclin D1 and p21 in MDA cells. The simultaneous induction and co-localization in the nucleus of cyclin D1 and p21 by TGFÎ² suggested that they may be physically associated with each other. To address this, we performed co-immunoprecipitation of p21 and cyclin D1 in MDA and SCP2 cells treated with or without TGFÎ² for 6 or 24 hours. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig2">2C</a>, TGFÎ² stimulated the interaction between endogenous p21 with cyclin D1 in a time-dependent fashion in MDA and SCP2 cells. Reciprocal immunoprecipitation experiments confirmed that endogenous cyclin D1 specifically interacts with immunoprecipitated p21 in response to TGFÎ² in MDA cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig2">2D</a>, left panel). Moreover, the induction of complex formation between endogenous cyclin D1 and p21 was also observed in both SUM149 and SUM159 cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig2">2D</a>, middle and right panels). Collectively, these results indicated that TGFÎ² stimulates the formation of a complex between cyclin D1 and p21 in triple negative basal-like breast cancer cells.</p><h3 class="c-article__sub-heading" id="Sec14">Cyclin D1 is required for TGFÎ²-mediated cell migration</h3><p>Given that TGFÎ² enhanced cyclin D1 and p21 expression and complex formation in these human metastatic breast cancer cells, we investigated whether the TGFÎ² pro-migratory effect is mediated through cyclin D1. To address this, SCP2 cells were transfected with scrambled (Scr) siRNA or cyclin D1 siRNA. Cell migration in response to TGFÎ² was assessed by the scratch/wound healing assay coupled to quantitative time-lapsed imaging for up to 24 hours. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig3">3A</a>, TGFÎ²-induced cyclin D1 protein expression in the SCP2 cells transfected with Scr siRNA was blocked in cells transfected with cyclin D1 siRNA. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig3">3B, C</a>, while TGFÎ² stimulated rapid wound closure in SCP2 cells transfected with the Scr siRNA, this effect was delayed in SCP2 cells depleted of cyclin D1. TGFÎ²-induced wound closure was not affected by the mitotic inhibitor mitomycin C, suggesting that the effect of TGFÎ² on cell migration was independent of cell proliferation (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig3">3D</a>). We further assessed the role of cyclin D1 downstream of TGFÎ²-mediated cell migration, using a Transwell migration assay. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig3">3E, F</a>, knocking down cyclin D1 inhibited the TGFÎ² pro-migratory effects, consistent with what observed with the wound healing assay (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig3">3B, C</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Figure 3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig3_HTML.jpg?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig3_HTML.jpg" alt="figure 3" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>
                                                    <b>Cyclin D1 is required for TGFÎ²-mediated cell migration</b>. <b>(A)</b> SCP2 cells were transfected with Scr or cyclin D1 siRNAs and then treated with or without 5 ng/ml transforming growth factor beta(TGFÎ²) for 24 hours. Total cell lysates were analyzed for cyclin D1 and Î²-tubulin by Western blotting. <b>(B)</b> Representative images of phase contrast and wound mask of transfected SCP2 cells stimulated without or with TGFÎ² for 0 and 24 hours in scratch/wound healing assay. The initial wound mask (black) and wound closure (grey) were measured using the Essen Instruments Scratch Wound Module. <b>(C)</b> Relative wound width was analyzed by the IncuCyteâ¢software (Essen Bioscience) and quantified for the indicated times (error bars indicate SEM; <i>n</i> = 3 independent experiments). <b>(D)</b> SCP2 cells were treated with either vehicle (dimethyl sulfoxide, DMSO) or mitomycin C (Mito C) in the presence or absence of TGFÎ². SCP2 cell migration was quantified using wound closure area at 24 hours (error bars indicate SEM; <i>n</i> = 3 independent experiments). <b>(E)</b> Representative images of transfected SCP2 cells stimulated with or without TGFÎ² for 0 and 24 hours in Transwell cell migration assay. Cells were stained with 0.2% crystal violet. <b>(F)</b> Transfected and migrated SCP2 cells in Transwell migration assay were stained with DRAQ5 fluorescent dye and quantified using fluorescent density at 24 hours (error bars indicate SEM; <i>n</i> = 3 independent experiments). <b>(G)</b> SCP2 cells were transfected with empty vector, Flag-p21, and HA-cyclin D1 separately or in combination. TGFÎ²-mediated cell migration was assessed using the Transwell (top panel) and wound healing (bottom panel) assays. Migration of the cells was quantified using fluorescent density (Transwell assay) and wound closure area (wound healing assay) at 24 hours (Error bars indicate SEM; <i>n</i> = 3 independent experiments).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
                                <p>To then address whether cyclin D1 and p21 have any synergistic effect, p21 and cyclin D1 cDNAs were overexpressed alone or in combination and the TGFÎ² effect on cell migration was examined using both the wound healing and Transwell migration assays. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig3">3G</a>, overexpression of cyclin D1 or p21 alone had little or no potentiation effect on TGFÎ²-induced cell migration. However, overexpression of both proteins clearly increased/potentiated the TGFÎ² effect, suggesting that these two proteins synergize their effect downstream of TGFÎ². This is consistent with our main finding and conclusion, showing that the two proteins cooperate to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion. Together, these results demonstrate that cyclin D1 is required for TGFÎ²-mediated migration in breast cancer cells.</p><h3 class="c-article__sub-heading" id="Sec15">Cyclin D1 is a downstream mediator in TGFÎ²-regulated actin reorganization and invadopodia formation</h3><p>Cyclin D1 has previously been reported to regulate cellular migration in primary bone macrophages, mouse embryo fibroblasts (MEFs), and breast cancer cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, Pestell RG: Cyclin D1 governs adhesion and motility of macrophages.&#xA;                                    Mol Biol Cell 2003, 14:2005â2015." href="/articles/10.1186/bcr3441#ref-CR52" id="ref-link-section-d169286048e1114">52</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA: Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.&#xA;                                    Cancer Res 2010, 70:2105â2114." href="/articles/10.1186/bcr3441#ref-CR54" id="ref-link-section-d169286048e1117">54</a>]. For instance, cyclin D1-deficient MEFs display a more spread phenotype, and an increased cell adhesion and actin stress fiber formation through inhibition of thrombospondin 1 and ROCK signaling [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, Zhang X, Li A, Burbelo P, Stanley ER, Pestell RG: Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling.&#xA;                                    Mol Cell Biol 2006, 26:4240â4256." href="/articles/10.1186/bcr3441#ref-CR53" id="ref-link-section-d169286048e1120">53</a>]. Therefore, we examined whether cyclin D1 effects on cellular structure and actin organization contribute to TGFÎ²-mediated cancer cell migration. To this end, SCP2 cells transfected with either Scr or cyclin D1 siRNAs were stimulated with TGFÎ² and the dynamics of actin organization were assessed by staining with the fluorescently labeled F-actin marker phalloidin and mesenchymal intermediate filament vimentin. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig4">4A</a>, vimentin filaments co-localized with F-actin at the leading edge of aggressive SCP2 cells transfected with Scr siRNA, which displayed an elongated phenotype in response to TGFÎ². Interestingly, cyclin D1-deficient cells were rounded and exhibited more epithelial-like phenotype. Furthermore, suppression of cyclin D1 expression not only prevented the elongation of vimentin filaments, but also the co-localization with F-actin at the cell edge.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Figure 4"><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 4</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig4_HTML.jpg?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig4_HTML.jpg" alt="figure 4" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p>
                                                    <b>Cyclin D1 is a downstream mediator in TGFÎ²-regulated actin reorganization and invadopodia formation</b>. <b>(A)</b> Scr siRNA- or cyclin D1 siRNA-transfected SCP2 cells were treated with or without 5 ng/ml transforming growth factor beta (TGFÎ²) for 24 hours. Immunocytochemistry was performed using F-actin (green) antibody, vimentin (red) antibody and DAPI (blue). Co-localizaton (yellow) between F-actin and vimentin is represented by overlay. The scale bar is 10 Âµm. <b>(B)</b> Scr siRNA- or cyclin D1 siRNA-transfected SCP2 cells were cultured on the top of growth factor-reduced Matrigel and then treated with or without 5 ng/ml TGFÎ² for 24 hours. Immunocytochemistry was performed using F-actin (green) and cyclin D1 (red) antibodies and DAPI (blue).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
                                <p>Vimentin is required for the elongation of invadopodia subcellular structures, which are three-dimensional actin-rich protrusions [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Schoumacher M, Goldman RD, Louvard D, Vignjevic DM: Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia.&#xA;                                    J Cell Biol 2010, 189:541â556." href="/articles/10.1186/bcr3441#ref-CR55" id="ref-link-section-d169286048e1157">55</a>]. Invadopodia are selectively found in invasive cancer cells and are important for the degradation of the ECM [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Weaver AM: Invadopodia: specialized cell structures for cancer invasion.&#xA;                                    Clin Exp Metastasis 2006, 23:97â105." href="/articles/10.1186/bcr3441#ref-CR56" id="ref-link-section-d169286048e1160">56</a>]. As cyclin D1 affects vimentin distribution, we investigated whether cyclin D1 could regulate invadopodia formation. SCP2 cells transfected with either Scr or cyclin D1 siRNAs were seeded on top of growth factor-reduced Matrigel and treated with or without TGFÎ². Whereas Scr-transfected SCP2 cells stimulated with TGFÎ² showed increased F-actin-bundled protrusion and invaded into the Matrigel, this phenotype was completely abolished by knocking down cyclin D1 expression (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig4">4B</a>). All together, these results defined novel functions for cyclin D1 as a TGFÎ² downstream target that is required for this growth factor to mediate vimentin elongation, induction of a migratory morphological phenotype, and the formation of invasive subcellular structures in metastatic breast cancer cells.</p><h3 class="c-article__sub-heading" id="Sec16">Depletion of cyclin D1 and p21 prevents mammary tumor growth and local invasion</h3><p>Overexpression of p21 and cyclin D1 is correlated with poor prognosis and aggressiveness in breast cancer. To address the importance of p21 and cyclin D1 on breast cancer development <i>in vivo</i>, we injected either SCP2 control or double p21 and cyclin D1 knockdown cells into the mammary fat pads of female Balb/c nude mice to monitor primary tumor growth and local invasiveness. Silencing p21 and cyclin D1 expression using siRNAs significantly reduced the rate of primary tumor formation and tumor size (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig5">5A</a>). As depletion of p21 alone did not affect tumor formation in a Xenograft transplantation <i>in vivo</i> model [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Schoumacher M, Goldman RD, Louvard D, Vignjevic DM: Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia.&#xA;                                    J Cell Biol 2010, 189:541â556." href="/articles/10.1186/bcr3441#ref-CR55" id="ref-link-section-d169286048e1184">55</a>], it is likely that the observed phenotype on tumor formation in the double knockdown is mediated by cyclin D1. This is in agreement with previous studies showing that depletion of cyclin D1 prevented tumor development in oncogenic HER2 overexpressing transgenic mice [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG: Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.&#xA;                                    Mol Cell Biol 2000, 20:672â683." href="/articles/10.1186/bcr3441#ref-CR57" id="ref-link-section-d169286048e1187">57</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P: Mouse development and cell proliferation in the absence of D-cyclins.&#xA;                                    Cell 2004, 118:477â491." href="/articles/10.1186/bcr3441#ref-CR59" id="ref-link-section-d169286048e1191">59</a>]. Importantly, three out of six mice in the control group had tumors ulcerating through the overlaying skin, while all the mice in the double knockdown group had intact skin. Breast tumor with ulcerated skin has been clinically classified as locally advanced breast cancer. All tumors were taken with the overlaying skin and surrounding tissues and subjected to hematoxylin and eosin staining. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig5">5B</a>, the deep tumor margins in the control group were less distinct, invading nearby structures, including skeletal muscles and the mammary fat pad, and showed frequent lymphovascular invasion. However, the tumor margins in the knockdown group were well encapsulated with a non-invasive nature. In addition, we performed immunohistochemistry on primary mammary tumor derived from animals injected with parental and p21/cyclin D1-depleted SCP2 cells. We assessed the expression of the TGFÎ²-regulated gene PTGS2, which we have previously shown to be involved in mediating the TGFÎ² effect on cell migration and invasion [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e1197">44</a>]. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig5">5C</a>, using tumors from four different mice in each group, we found expression of PTGS2 to be clearly higher in parental tumors compared to p21/cyclin D1-depleted tumors, further confirming that the p21/cyclin D1-depleted tumors displayed less invasive features.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Figure 5"><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 5</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig5_HTML.jpg?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3441/MediaObjects/13058_2012_3246_Fig5_HTML.jpg" alt="figure 5" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p>
                                                    <b>Depletion of cyclin D1 and p21 prevents mammary tumor growth and local invasion</b>. <b>(A)</b> Parental SCP2 and p21/cyclin D1 double knockdown SCP2 cells were implanted into the mammary fat pad of four- to six-week-old female Balb/c nude mice. Mammary tumor growth was measured from two sets of mice and quantified for the tumor size at the indicated times (six per group; error bars indicate SEM). <b>(B)</b> Representative photographs show hematoxylin and eosin staining of the mammary gland (tumor and surrounding tissues) of mice at eight weeks post-injection. <b>(C)</b> Representative photographs show PTGS2 staining of parental and p21/cyclin D1-depleted mammary tumor of mice at eight weeks post-injection. <b>(D)</b> Representative radiographs of skeletal lesions in two groups of mice (parental and p21/cyclin D1-depleted SCP2) were taken by X-ray using Faxitron. Parental and p21/cyclin D1-depleted SCP2 cells were injected in tibia. The lesions are highlighted by arrows.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3441/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
                                <p>To investigate the role of p21 and cyclin D1 on the development of bone osteolytic lesions, parental and double knockdown SCP2 cells were injected intramuscularly into the left tibia of two groups of nude mice. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3441#Fig5">5D</a>, following X-ray examination of the bones, both group of mice developed secondary tumors that caused severe osteolytic bone lesions, suggesting that p21/cyclin D1 do not affect the later stages of bone metastasis. Collectively, these results indicate that while p21 and cyclin D1 are required for breast cancer cells to acquire an invasive phenotype, their effects are primarily occurring at the earlier stages of tumor metastasis, namely induction of local cell invasion from the tumor to the surrounding tissues. This is also consistent with previous work, showing that depletion of p21 alone did not affect the development of bone osteolytic lesions [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.&#xA;                                    Breast Cancer Res 2012, 14:R127." href="/articles/10.1186/bcr3441#ref-CR44" id="ref-link-section-d169286048e1243">44</a>].</p></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec17-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec17">Discussion</h2><div class="c-article-section__content" id="Sec17-content"><p>Cyclin D1 is a well-characterized oncogene that is frequently overexpressed in human breast, lung, colon, prostate and hematopoietic carcinomas [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Arnold A, Papanikolaou A: Cyclin D1 in breast cancer pathogenesis.&#xA;                                    J Clin Oncol 2005, 23:4215â4224." href="/articles/10.1186/bcr3441#ref-CR60" id="ref-link-section-d169286048e1255">60</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS: A census of amplified and overexpressed human cancer genes.&#xA;                                    Nat Rev Cancer 2010, 10:59â64." href="/articles/10.1186/bcr3441#ref-CR62" id="ref-link-section-d169286048e1258">62</a>]. This is a unique feature among the three closely related D type G1 cyclins (D1, D2 and D3), as amplification of cyclin D2 and D3 copy-number is rarely observed in human cancer. In fact, methylation of cyclin D2 resulting in loss of its expression has been reported in breast, pancreatic and prostate cancer [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Hruban RH, Goggins M: Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.&#xA;                                    Clin Cancer Res 2003, 9:1446â1452." href="/articles/10.1186/bcr3441#ref-CR63" id="ref-link-section-d169286048e1261">63</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF: Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.&#xA;                                    Clin Cancer Res 2003, 9:4730â4734." href="/articles/10.1186/bcr3441#ref-CR65" id="ref-link-section-d169286048e1264">65</a>]. In addition to the association between cyclin D1 expression and human cancer, overexpression of cyclin D1 is tumorigenic, as supported by evidence that MMTV-driven cyclin D1 is sufficient for mammary hyperplasia and carcinoma development in transgenic mice [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.&#xA;                                    Nature 1994, 369:669â671." href="/articles/10.1186/bcr3441#ref-CR66" id="ref-link-section-d169286048e1267">66</a>]. Furthermore, cyclin D1 is required for many oncogenes, such as HER2 or Ras, to induce mammary tumor growth in mice [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG: Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.&#xA;                                    Mol Cell Biol 2000, 20:672â683." href="/articles/10.1186/bcr3441#ref-CR57" id="ref-link-section-d169286048e1271">57</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P: Mouse development and cell proliferation in the absence of D-cyclins.&#xA;                                    Cell 2004, 118:477â491." href="/articles/10.1186/bcr3441#ref-CR59" id="ref-link-section-d169286048e1274">59</a>]. The function of cyclin D1 in mammary oncogenesis in mice is mediated through the activation of its regulatory partner CDK4, as mice lacking CDK4 or expressing the CDK4/CDK6-specific inhibitor INK4A are resistant to HER2-induced mammary tumor formation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Yu Q, Geng Y, Sicinski P: Specific protection against breast cancers by cyclin D1 ablation.&#xA;                                    Nature 2001, 411:1017â1021." href="/articles/10.1186/bcr3441#ref-CR58" id="ref-link-section-d169286048e1277">58</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW: Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.&#xA;                                    Cancer Cell 2006, 9:13â22." href="/articles/10.1186/bcr3441#ref-CR67" id="ref-link-section-d169286048e1280">67</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Yang C, Ionescu-Tiba V, Burns K, Gadd M, Zukerberg L, Louis DN, Sgroi D, Schmidt EV: The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer.&#xA;                                    Am J Pathol 2004, 164:1031â1038." href="/articles/10.1186/bcr3441#ref-CR69" id="ref-link-section-d169286048e1283">69</a>]. While these studies addressed the importance of cyclin D1 on breast tumor initiation, its contribution to the development and progression of established tumors remains unclear.</p><p>Several studies support the notion that the oncogenic effects of cyclin D1 may not be simply due to enhanced tumor cell growth or proliferation. For instance, cyclin D1 expression did not correlate with Ki67 expression in a cohort of 779 breast cancer patients [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT: Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.&#xA;                                    Clin Cancer Res 2009, 15:3654â3662." href="/articles/10.1186/bcr3441#ref-CR45" id="ref-link-section-d169286048e1289">45</a>]. In another study of 1,740 breast cancer patients, cyclin D1 expression was not tightly associated with proliferative genes that are regulated by the inactivation of CDK4 substrate RB [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, Knudsen ES: RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.&#xA;                                    Cell Cycle 2010, 9:4153â4163." href="/articles/10.1186/bcr3441#ref-CR46" id="ref-link-section-d169286048e1292">46</a>]. In addition, high expression of cyclin D1 is associated with high incidence of metastasis and poor survival outcome [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C: Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.&#xA;                                    Clin Cancer Res 2000, 6:1891â1895." href="/articles/10.1186/bcr3441#ref-CR47" id="ref-link-section-d169286048e1295">47</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.&#xA;                                    Cancer Res 1994, 54:4813â4817." href="/articles/10.1186/bcr3441#ref-CR48" id="ref-link-section-d169286048e1298">48</a>]. Therefore, cyclin D1 is potentially required for continual development and progression of established tumors.</p><p>In this study, we investigated the function of cyclin D1 on breast tumor progression induced by TGFÎ², a potent tumor-promoting factor, in metastatic breast cancer cell lines. Our results showed that the effect of TGFÎ² on cyclin D1 expression was specific, as protein levels of other cyclins in G1, S and M phase are unresponsive to TGFÎ² stimulation. Furthermore, using a panel of tumorigenic triple negative breast cancer cell lines, which exhibit differential responses to TGFÎ² in terms of cellular migration, we found cyclin D1 expression to correlate with p21 expression and to be required for TGFÎ²-induced cell migration. Furthermore, up-regulation of the cyclin D1 gene by TGFÎ² is more potent and persistent in highly migratory cell lines compared with less motile cells. This is consistent with a previous study using intravital imaging of live tumor-bearing nude mice, showing that although TGFÎ² signaling promotes single tumor cell migration and metastatic spread into blood vessels and lymph nodes, not all cells with active TGFÎ² signaling are migratory [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E: Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility.&#xA;                                    Nat Cell Biol 2009, 11:1287â1296." href="/articles/10.1186/bcr3441#ref-CR12" id="ref-link-section-d169286048e1304">12</a>]. Our results suggest that cyclin D1 is a specific downstream target for TGFÎ²-mediated cell migration.</p><p>Subcellular localization and stabilization of cyclin D1 play an important role in human cancers [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D: Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.&#xA;                                    Oncogene 1999, 18:1983â1991." href="/articles/10.1186/bcr3441#ref-CR70" id="ref-link-section-d169286048e1310">70</a>]. We showed a TGFÎ²-induced nuclear localization of cyclin D1 in these metastatic breast cancer cell lines. It has been demonstrated that oncogenic actions of cyclin D1 are predominantly nuclear in many cancers, as carcinogenic mutations and deletions often occur at the T286 site, which controls cyclin D1 protein turnover and nuclear export [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA: Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.&#xA;                                    Oncogene 2006, 25:6291â6303." href="/articles/10.1186/bcr3441#ref-CR71" id="ref-link-section-d169286048e1313">71</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Moreno-Bueno G, Rodriguez-Perales S, Sanchez-Estevez C, Hardisson D, Sarrio D, Prat J, Cigudosa JC, Matias-Guiu X, Palacios J: Cyclin D1 gene (CCND1) mutations in endometrial cancer.&#xA;                                    Oncogene 2003, 22:6115â6118." href="/articles/10.1186/bcr3441#ref-CR72" id="ref-link-section-d169286048e1316">72</a>]. Mutated cyclin D1 with constitutive nuclear localization and impaired degradation not only enhanced cyclin D1 transformation efficiency <i>in vitro</i>, but also promoted tumor formation <i>in vivo</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Kim JK, Diehl JA: Nuclear cyclin D1: an oncogenic driver in human cancer.&#xA;                                    J Cell Physiol 2009, 220:292â296." href="/articles/10.1186/bcr3441#ref-CR73" id="ref-link-section-d169286048e1326">73</a>]. Our study further revealed that TGFÎ²-induced nuclear cyclin D1 promotes cell migration by altering cell morphology and the formation of invasive subcellular structures in metastatic breast cancer cells.</p><p>Cyclin D1 has been recognized as a multifunctional protein, which regulates angiogenesis, lipogenesis, mitochondrial function and cell migration [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, Zhang X, Li A, Burbelo P, Stanley ER, Pestell RG: Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling.&#xA;                                    Mol Cell Biol 2006, 26:4240â4256." href="/articles/10.1186/bcr3441#ref-CR53" id="ref-link-section-d169286048e1333">53</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA: Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.&#xA;                                    Cancer Res 2010, 70:2105â2114." href="/articles/10.1186/bcr3441#ref-CR54" id="ref-link-section-d169286048e1336">54</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, Fu M, Leader JE, Quong A, Novikoff PM, Pestell RG: Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function.&#xA;                                    Proc Natl Acad Sci USA 2006, 103:11567â11572." href="/articles/10.1186/bcr3441#ref-CR74" id="ref-link-section-d169286048e1339">74</a>â<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 78" title="Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG: Cyclin D1 induction of cellular migration requires p27(KIP1).&#xA;                                    Cancer Res 2006, 66:9986â9994." href="/articles/10.1186/bcr3441#ref-CR78" id="ref-link-section-d169286048e1342">78</a>]. A recent study identified that more than 100 cyclin D1-interacting proteins are involved in the regulation of cell cycle, transcription, DNA repair, RNA metabolism, protein folding and cell structure [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 79" title="Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP, Sicinski P: A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.&#xA;                                    Nature 2011, 474:230â234." href="/articles/10.1186/bcr3441#ref-CR79" id="ref-link-section-d169286048e1345">79</a>], suggesting that these interactors might influence various biological functions of cyclin D1. It has been shown that p21 interacts with cyclin D1 to promote nuclear accumulation of cyclin D1 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Alt JR, Gladden AB, Diehl JA: p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export.&#xA;                                    J Biol Chem 2002, 277:8517â8523." href="/articles/10.1186/bcr3441#ref-CR80" id="ref-link-section-d169286048e1349">80</a>]. In addition, cyclin D1 associates with p21 to facilitate DNA repair, and this function of cyclin D1 is independent of CDK4 activation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 81" title="Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O, Wang M, Soutoglou E, Knudsen ES, Pestell RG: Alternative cyclin D1 splice forms differentially regulate the DNA damage response.&#xA;                                    Cancer Res 2010, 70:8802â8811." href="/articles/10.1186/bcr3441#ref-CR81" id="ref-link-section-d169286048e1352">81</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 82" title="Raderschall E, Bazarov A, Cao J, Lurz R, Smith A, Mann W, Ropers HH, Sedivy JM, Golub EI, Fritz E, Haaf T: Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis.&#xA;                                    J Cell Sci 2002, 115:153â164." href="/articles/10.1186/bcr3441#ref-CR82" id="ref-link-section-d169286048e1355">82</a>]. We demonstrated that in the context of TGFÎ² signaling, cyclin D1 associates with p21 in metastatic breast cancer cells. Furthermore, depletion of cyclin D1 and p21 prevented mammary tumor formation and subsequent local invasion into surrounding tissues. Our previous study showed that p21 is required for TGFÎ²-mediated cell migration and invasion; therefore, these results not only highlight cyclin D1 as a novel TGFÎ² downstream target, but also indicate that cyclin D1 cooperates with p21 to mediate the effect of TGFÎ² on breast cancer progression.</p></div></div></section><section data-title="Conclusions"><div class="c-article-section" id="Sec18-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec18">Conclusions</h2><div class="c-article-section__content" id="Sec18-content"><p>In this study, we showed that TGFÎ² significantly induced cyclin D1 expression in metastatic breast cancer cells. TGFÎ²-induced cyclin D1 and p21 proteins remain mostly co-localized in the nucleus and physically interact with each other. Importantly, we found that up-regulated p21 and cyclin D1 play an important role in TGFÎ² regulation of cellular migration and invasion by actin remodeling. These results suggest that cyclin D1 and p21 may cooperate with each other to mediate the tumor-promoting effects of TGFÎ² in aggressive breast cancer cells.</p></div></div></section>
                    <section data-title="Abbreviations"><div class="c-article-section" id="abbreviations-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="abbreviations">Abbreviations</h2><div class="c-article-section__content" id="abbreviations-content"><dl class="c-abbreviation_list"><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>BSA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>bovine serum albumin</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>CDKs:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>cyclin-dependent kinases</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>CDKIs:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>cyclin-dependent kinases inhibitors</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMEM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Dulbecco's Modified Eagle Medium</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMSO:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>dimethyl sulfoxide</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ECM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>extracellular matrix</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>EGF:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>epidermal growth factor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>EMT:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>epithelial to mesenchymal transition</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>FBS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>fetal bovine serum</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MEF:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>mouse embryo fibroblast</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>p21:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>p21CIP1/WAF1</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>R-Smads:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>receptor-regulated Smads</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SDS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>sodium dodecyl sulfate</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TGFÎ²:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>transforming growth factor beta</p>
                  </dd></dl></div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Gupta GP, Massague J: <b>Cancer metastasis: building a framework.</b>
                                    <i>Cell</i> 2006, <b>127:</b>679â695.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28Xht1yqs7rL" aria-label="CAS reference 1">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2006.11.001" aria-label="Article reference 1">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17110329" aria-label="PubMed reference 1" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Cancer%20metastasis%3A%20building%20a%20framework&amp;journal=Cell&amp;volume=127&amp;pages=679-695&amp;publication_year=2006&amp;author=Gupta%2CGP&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Fidler IJ: <b>The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.</b>
                                    <i>Nat Rev Cancer</i> 2003, <b>3:</b>453â458.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXktFOnsbg%3D" aria-label="CAS reference 2">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc1098" aria-label="Article reference 2">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12778135" aria-label="PubMed reference 2" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20pathogenesis%20of%20cancer%20metastasis%3A%20the%20%27seed%20and%20soil%27%20hypothesis%20revisited&amp;journal=Nat%20Rev%20Cancer&amp;volume=3&amp;pages=453-458&amp;publication_year=2003&amp;author=Fidler%2CIJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Mack GS, Marshall A: <b>Lost in migration.</b>
                                    <i>Nat Biotechnol</i> 2010, <b>28:</b>214â229.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXivV2rsb0%3D" aria-label="CAS reference 3">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnbt0310-214" aria-label="Article reference 3">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20212481" aria-label="PubMed reference 3" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Lost%20in%20migration&amp;journal=Nat%20Biotechnol&amp;volume=28&amp;pages=214-229&amp;publication_year=2010&amp;author=Mack%2CGS&amp;author=Marshall%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Shi Y, Massague J: <b>Mechanisms of TGF-beta signaling from cell membrane to the nucleus.</b>
                                    <i>Cell</i> 2003, <b>113:</b>685â700.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXkvVekt7o%3D" aria-label="CAS reference 4">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0092-8674%2803%2900432-X" aria-label="Article reference 4">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12809600" aria-label="PubMed reference 4" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20TGF-beta%20signaling%20from%20cell%20membrane%20to%20the%20nucleus&amp;journal=Cell&amp;volume=113&amp;pages=685-700&amp;publication_year=2003&amp;author=Shi%2CY&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Bierie B, Moses HL: <b>Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.</b>
                                    <i>Nat Rev Cancer</i> 2006, <b>6:</b>506â520.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XmtFegsr4%3D" aria-label="CAS reference 5">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc1926" aria-label="Article reference 5">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16794634" aria-label="PubMed reference 5" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Tumour%20microenvironment%3A%20TGFbeta%3A%20the%20molecular%20Jekyll%20and%20Hyde%20of%20cancer&amp;journal=Nat%20Rev%20Cancer&amp;volume=6&amp;pages=506-520&amp;publication_year=2006&amp;author=Bierie%2CB&amp;author=Moses%2CHL">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA: <b>Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.</b>
                                    <i>Cell</i> 2011, <b>145:</b>926â940.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXnsVOkt7s%3D" aria-label="CAS reference 6">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2011.04.029" aria-label="Article reference 6">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21663795" aria-label="PubMed reference 6" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930331" aria-label="PubMed Central reference 6" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Paracrine%20and%20autocrine%20signals%20induce%20and%20maintain%20mesenchymal%20and%20stem%20cell%20states%20in%20the%20breast&amp;journal=Cell&amp;volume=145&amp;pages=926-940&amp;publication_year=2011&amp;author=Scheel%2CC&amp;author=Eaton%2CEN&amp;author=Li%2CSH&amp;author=Chaffer%2CCL&amp;author=Reinhardt%2CF&amp;author=Kah%2CKJ&amp;author=Bell%2CG&amp;author=Guo%2CW&amp;author=Rubin%2CJ&amp;author=Richardson%2CAL&amp;author=Weinberg%2CRA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Labelle M, Begum S, Hynes RO: <b>Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.</b>
                                    <i>Cancer Cell</i> 2011, <b>20:</b>576â590.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhsFSktLnJ" aria-label="CAS reference 7">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.ccr.2011.09.009" aria-label="Article reference 7">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22094253" aria-label="PubMed reference 7" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487108" aria-label="PubMed Central reference 7" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Direct%20signaling%20between%20platelets%20and%20cancer%20cells%20induces%20an%20epithelial-mesenchymal-like%20transition%20and%20promotes%20metastasis&amp;journal=Cancer%20Cell&amp;volume=20&amp;pages=576-590&amp;publication_year=2011&amp;author=Labelle%2CM&amp;author=Begum%2CS&amp;author=Hynes%2CRO">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Dumont N, Arteaga CL: <b>Targeting the TGF beta signaling network in human neoplasia.</b>
                                    <i>Cancer Cell</i> 2003, <b>3:</b>531â536.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXltlSms7c%3D" aria-label="CAS reference 8">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS1535-6108%2803%2900135-1" aria-label="Article reference 8">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12842082" aria-label="PubMed reference 8" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeting%20the%20TGF%20beta%20signaling%20network%20in%20human%20neoplasia&amp;journal=Cancer%20Cell&amp;volume=3&amp;pages=531-536&amp;publication_year=2003&amp;author=Dumont%2CN&amp;author=Arteaga%2CCL">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Derynck R, Akhurst RJ, Balmain A: <b>TGF-beta signaling in tumor suppression and cancer progression.</b>
                                    <i>Nat Genet</i> 2001, <b>29:</b>117â129.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXnsFKgt7c%3D" aria-label="CAS reference 9">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fng1001-117" aria-label="Article reference 9">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11586292" aria-label="PubMed reference 9" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20signaling%20in%20tumor%20suppression%20and%20cancer%20progression&amp;journal=Nat%20Genet&amp;volume=29&amp;pages=117-129&amp;publication_year=2001&amp;author=Derynck%2CR&amp;author=Akhurst%2CRJ&amp;author=Balmain%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Akhurst RJ, Derynck R: <b>TGF-beta signaling in cancer--a double-edged sword.</b>
                                    <i>Trends Cell Biol</i> 2001, <b>11:</b>S44â51.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXnvFGrsb8%3D" aria-label="CAS reference 10">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11684442" aria-label="PubMed reference 10" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20signaling%20in%20cancer--a%20double-edged%20sword&amp;journal=Trends%20Cell%20Biol&amp;volume=11&amp;pages=S44-51&amp;publication_year=2001&amp;author=Akhurst%2CRJ&amp;author=Derynck%2CR">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">Wakefield LM, Roberts AB: <b>TGF-beta signaling: positive and negative effects on tumorigenesis.</b>
                                    <i>Curr Opin Genet Dev</i> 2002, <b>12:</b>22â29.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XktFGmtw%3D%3D" aria-label="CAS reference 11">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0959-437X%2801%2900259-3" aria-label="Article reference 11">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11790550" aria-label="PubMed reference 11" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20signaling%3A%20positive%20and%20negative%20effects%20on%20tumorigenesis&amp;journal=Curr%20Opin%20Genet%20Dev&amp;volume=12&amp;pages=22-29&amp;publication_year=2002&amp;author=Wakefield%2CLM&amp;author=Roberts%2CAB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E: <b>Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility.</b>
                                    <i>Nat Cell Biol</i> 2009, <b>11:</b>1287â1296.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtlCnu7rN" aria-label="CAS reference 12">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fncb1973" aria-label="Article reference 12">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19838175" aria-label="PubMed reference 12" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773241" aria-label="PubMed Central reference 12" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Localized%20and%20reversible%20TGFbeta%20signalling%20switches%20breast%20cancer%20cells%20from%20cohesive%20to%20single%20cell%20motility&amp;journal=Nat%20Cell%20Biol&amp;volume=11&amp;pages=1287-1296&amp;publication_year=2009&amp;author=Giampieri%2CS&amp;author=Manning%2CC&amp;author=Hooper%2CS&amp;author=Jones%2CL&amp;author=Hill%2CCS&amp;author=Sahai%2CE">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP, Lin K: <b>The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization.</b>
                                    <i>Nat Struct Biol</i> 2001, <b>8:</b>248â253.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXhs1Khs7w%3D" aria-label="CAS reference 13">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F84995" aria-label="Article reference 13">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11224571" aria-label="PubMed reference 13" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20L3%20loop%20and%20C-terminal%20phosphorylation%20jointly%20define%20Smad%20protein%20trimerization&amp;journal=Nat%20Struct%20Biol&amp;volume=8&amp;pages=248-253&amp;publication_year=2001&amp;author=Chacko%2CBM&amp;author=Qin%2CB&amp;author=Correia%2CJJ&amp;author=Lam%2CSS&amp;author=de%20Caestecker%2CMP&amp;author=Lin%2CK">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, de Caestecker M, Lin K: <b>Structural basis of heteromeric smad protein assembly in TGF-beta signaling.</b>
                                    <i>Mol Cell</i> 2004, <b>15:</b>813â823.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXnvFyhs7g%3D" aria-label="CAS reference 14">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.molcel.2004.07.016" aria-label="Article reference 14">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15350224" aria-label="PubMed reference 14" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Structural%20basis%20of%20heteromeric%20smad%20protein%20assembly%20in%20TGF-beta%20signaling&amp;journal=Mol%20Cell&amp;volume=15&amp;pages=813-823&amp;publication_year=2004&amp;author=Chacko%2CBM&amp;author=Qin%2CBY&amp;author=Tiwari%2CA&amp;author=Shi%2CG&amp;author=Lam%2CS&amp;author=Hayward%2CLJ&amp;author=de%20Caestecker%2CM&amp;author=Lin%2CK">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">Shi Y, Wang YF, Jayaraman L, Yang H, Massague J, Pavletich NP: <b>Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling.</b>
                                    <i>Cell</i> 1998, <b>94:</b>585â594.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1cXmtVWlu7c%3D" aria-label="CAS reference 15">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0092-8674%2800%2981600-1" aria-label="Article reference 15">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9741623" aria-label="PubMed reference 15" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Crystal%20structure%20of%20a%20Smad%20MH1%20domain%20bound%20to%20DNA%3A%20insights%20on%20DNA%20binding%20in%20TGF-beta%20signaling&amp;journal=Cell&amp;volume=94&amp;pages=585-594&amp;publication_year=1998&amp;author=Shi%2CY&amp;author=Wang%2CYF&amp;author=Jayaraman%2CL&amp;author=Yang%2CH&amp;author=Massague%2CJ&amp;author=Pavletich%2CNP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">Massague J, Wotton D: <b>Transcriptional control by the TGF-beta/Smad signaling system.</b>
                                    <i>EMBO J</i> 2000, <b>19:</b>1745â1754.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXivVKlsbo%3D" aria-label="CAS reference 16">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1093%2Femboj%2F19.8.1745" aria-label="Article reference 16">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10775259" aria-label="PubMed reference 16" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC302010" aria-label="PubMed Central reference 16" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Transcriptional%20control%20by%20the%20TGF-beta%2FSmad%20signaling%20system&amp;journal=EMBO%20J&amp;volume=19&amp;pages=1745-1754&amp;publication_year=2000&amp;author=Massague%2CJ&amp;author=Wotton%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Massague J: <b>TGFbeta signalling in context.</b>
                                    <i>Nat Rev Mol Cell Biol</i> 2012, <b>13:</b>616â630.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhtlKrs73I" aria-label="CAS reference 17">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrm3434" aria-label="Article reference 17">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22992590" aria-label="PubMed reference 17" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027049" aria-label="PubMed Central reference 17" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=TGFbeta%20signalling%20in%20context&amp;journal=Nat%20Rev%20Mol%20Cell%20Biol&amp;volume=13&amp;pages=616-630&amp;publication_year=2012&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Massague J: <b>G1 cell-cycle control and cancer.</b>
                                    <i>Nature</i> 2004, <b>432:</b>298â306.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXpvVCjt7c%3D" aria-label="CAS reference 18">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnature03094" aria-label="Article reference 18">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15549091" aria-label="PubMed reference 18" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=G1%20cell-cycle%20control%20and%20cancer&amp;journal=Nature&amp;volume=432&amp;pages=298-306&amp;publication_year=2004&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Besson A, Dowdy SF, Roberts JM: <b>CDK inhibitors: cell cycle regulators and beyond.</b>
                                    <i>Dev Cell</i> 2008, <b>14:</b>159â169.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXit1Ojsrc%3D" aria-label="CAS reference 19">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.devcel.2008.01.013" aria-label="Article reference 19">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18267085" aria-label="PubMed reference 19" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=CDK%20inhibitors%3A%20cell%20cycle%20regulators%20and%20beyond&amp;journal=Dev%20Cell&amp;volume=14&amp;pages=159-169&amp;publication_year=2008&amp;author=Besson%2CA&amp;author=Dowdy%2CSF&amp;author=Roberts%2CJM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Sherr CJ: <b>G1 phase progression: cycling on cue.</b>
                                    <i>Cell</i> 1994, <b>79:</b>551â555.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXit1Glu7o%3D" aria-label="CAS reference 20">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2894%2990540-1" aria-label="Article reference 20">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7954821" aria-label="PubMed reference 20" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=G1%20phase%20progression%3A%20cycling%20on%20cue&amp;journal=Cell&amp;volume=79&amp;pages=551-555&amp;publication_year=1994&amp;author=Sherr%2CCJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G: <b>CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.</b>
                                    <i>Oncogene</i> 1994, <b>9:</b>71â79.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXkslKqsL4%3D" aria-label="CAS reference 21">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8302605" aria-label="PubMed reference 21" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=CDK6%20%28PLSTIRE%29%20and%20CDK4%20%28PSK-J3%29%20are%20a%20distinct%20subset%20of%20the%20cyclin-dependent%20kinases%20that%20associate%20with%20cyclin%20D1&amp;journal=Oncogene&amp;volume=9&amp;pages=71-79&amp;publication_year=1994&amp;author=Bates%2CS&amp;author=Bonetta%2CL&amp;author=MacAllan%2CD&amp;author=Parry%2CD&amp;author=Holder%2CA&amp;author=Dickson%2CC&amp;author=Peters%2CG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Dulic V, Lees E, Reed SI: <b>Association of human cyclin E with a periodic G1-S phase protein kinase.</b>
                                    <i>Science</i> 1992, <b>257:</b>1958â1961.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3sXpvVKqtQ%3D%3D" aria-label="CAS reference 22">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1329201" aria-label="Article reference 22">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1329201" aria-label="PubMed reference 22" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20of%20human%20cyclin%20E%20with%20a%20periodic%20G1-S%20phase%20protein%20kinase&amp;journal=Science&amp;volume=257&amp;pages=1958-1961&amp;publication_year=1992&amp;author=Dulic%2CV&amp;author=Lees%2CE&amp;author=Reed%2CSI">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM: <b>Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.</b>
                                    <i>Science</i> 1992, <b>257:</b>1689â1694.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3sXlslSisQ%3D%3D" aria-label="CAS reference 23">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1388288" aria-label="Article reference 23">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1388288" aria-label="PubMed reference 23" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Formation%20and%20activation%20of%20a%20cyclin%20E-cdk2%20complex%20during%20the%20G1%20phase%20of%20the%20human%20cell%20cycle&amp;journal=Science&amp;volume=257&amp;pages=1689-1694&amp;publication_year=1992&amp;author=Koff%2CA&amp;author=Giordano%2CA&amp;author=Desai%2CD&amp;author=Yamashita%2CK&amp;author=Harper%2CJW&amp;author=Elledge%2CS&amp;author=Nishimoto%2CT&amp;author=Morgan%2CDO&amp;author=Franza%2CBR&amp;author=Roberts%2CJM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Meyerson M, Harlow E: <b>Identification of G1 kinase activity for cdk6, a novel cyclin D partner.</b>
                                    <i>Mol Cell Biol</i> 1994, <b>14:</b>2077â2086.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXivFCks7k%3D" aria-label="CAS reference 24">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.14.3.2077" aria-label="Article reference 24">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8114739" aria-label="PubMed reference 24" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC358568" aria-label="PubMed Central reference 24" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20G1%20kinase%20activity%20for%20cdk6%2C%20a%20novel%20cyclin%20D%20partner&amp;journal=Mol%20Cell%20Biol&amp;volume=14&amp;pages=2077-2086&amp;publication_year=1994&amp;author=Meyerson%2CM&amp;author=Harlow%2CE">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ: <b>Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.</b>
                                    <i>Cell</i> 1992, <b>71:</b>323â334.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3sXkvV2hs74%3D" aria-label="CAS reference 25">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2892%2990360-O" aria-label="Article reference 25">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1423597" aria-label="PubMed reference 25" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20and%20properties%20of%20an%20atypical%20catalytic%20subunit%20%28p34PSK-J3%2Fcdk4%29%20for%20mammalian%20D%20type%20G1%20cyclins&amp;journal=Cell&amp;volume=71&amp;pages=323-334&amp;publication_year=1992&amp;author=Matsushime%2CH&amp;author=Ewen%2CME&amp;author=Strom%2CDK&amp;author=Kato%2CJY&amp;author=Hanks%2CSK&amp;author=Roussel%2CMF&amp;author=Sherr%2CCJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Hannon GJ, Beach D: <b>p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest [see comments].</b>
                                    <i>Nature</i> 1994, <b>371:</b>257â261.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXmsVOqsbk%3D" aria-label="CAS reference 26">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F371257a0" aria-label="Article reference 26">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8078588" aria-label="PubMed reference 26" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=p15INK4B%20is%20a%20potential%20effector%20of%20TGF-beta-induced%20cell%20cycle%20arrest%20%5Bsee%20comments%5D&amp;journal=Nature&amp;volume=371&amp;pages=257-261&amp;publication_year=1994&amp;author=Hannon%2CGJ&amp;author=Beach%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Serrano M, Hannon GJ, Beach D: <b>A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.</b>
                                    <i>Nature</i> 1993, <b>366:</b>704â707.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXhsFOgu7Y%3D" aria-label="CAS reference 27">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F366704a0" aria-label="Article reference 27">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8259215" aria-label="PubMed reference 27" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20new%20regulatory%20motif%20in%20cell-cycle%20control%20causing%20specific%20inhibition%20of%20cyclin%20D%2FCDK4&amp;journal=Nature&amp;volume=366&amp;pages=704-707&amp;publication_year=1993&amp;author=Serrano%2CM&amp;author=Hannon%2CGJ&amp;author=Beach%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y: <b>Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.</b>
                                    <i>Genes Dev</i> 1994, <b>8:</b>2939â2952.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXivVWrt78%3D" aria-label="CAS reference 28">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.8.24.2939" aria-label="Article reference 28">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8001816" aria-label="PubMed reference 28" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Growth%20suppression%20by%20p18%2C%20a%20p16INK4%2FMTS1-%20and%20p14INK4B%2FMTS2-related%20CDK6%20inhibitor%2C%20correlates%20with%20wild-type%20pRb%20function&amp;journal=Genes%20Dev&amp;volume=8&amp;pages=2939-2952&amp;publication_year=1994&amp;author=Guan%2CKL&amp;author=Jenkins%2CCW&amp;author=Li%2CY&amp;author=Nichols%2CMA&amp;author=Wu%2CX&amp;author=O%27Keefe%2CCL&amp;author=Matera%2CAG&amp;author=Xiong%2CY">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ: <b>Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.</b>
                                    <i>Mol Cell Biol</i> 1995, <b>15:</b>2672â2681.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:STN:280:DyaK2M3lsl2nug%3D%3D" aria-label="CAS reference 29">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.15.5.2672" aria-label="Article reference 29">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7739547" aria-label="PubMed reference 29" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC230497" aria-label="PubMed Central reference 29" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Novel%20INK4%20proteins%2C%20p19%20and%20p18%2C%20are%20specific%20inhibitors%20of%20the%20cyclin%20D-dependent%20kinases%20CDK4%20and%20CDK6&amp;journal=Mol%20Cell%20Biol&amp;volume=15&amp;pages=2672-2681&amp;publication_year=1995&amp;author=Hirai%2CH&amp;author=Roussel%2CMF&amp;author=Kato%2CJY&amp;author=Ashmun%2CRA&amp;author=Sherr%2CCJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: <b>The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.</b>
                                    <i>Cell</i> 1993, <b>75:</b>805â816.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXhtVShsLk%3D" aria-label="CAS reference 30">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2893%2990499-G" aria-label="Article reference 30">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8242751" aria-label="PubMed reference 30" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20p21%20Cdk-interacting%20protein%20Cip1%20is%20a%20potent%20inhibitor%20of%20G1%20cyclin-dependent%20kinases&amp;journal=Cell&amp;volume=75&amp;pages=805-816&amp;publication_year=1993&amp;author=Harper%2CJW&amp;author=Adami%2CGR&amp;author=Wei%2CN&amp;author=Keyomarsi%2CK&amp;author=Elledge%2CSJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: <b>WAF1, a potential mediator of p53 tumor suppression.</b>
                                    <i>Cell</i> 1993, <b>75:</b>817â825.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXpslGguw%3D%3D" aria-label="CAS reference 31">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2893%2990500-P" aria-label="Article reference 31">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8242752" aria-label="PubMed reference 31" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=WAF1%2C%20a%20potential%20mediator%20of%20p53%20tumor%20suppression&amp;journal=Cell&amp;volume=75&amp;pages=817-825&amp;publication_year=1993&amp;author=el-Deiry%2CWS&amp;author=Tokino%2CT&amp;author=Velculescu%2CVE&amp;author=Levy%2CDB&amp;author=Parsons%2CR&amp;author=Trent%2CJM&amp;author=Lin%2CD&amp;author=Mercer%2CWE&amp;author=Kinzler%2CKW&amp;author=Vogelstein%2CB">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: <b>Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.</b>
                                    <i>Cell</i> 1994, <b>78:</b>59â66.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXlvF2hsb0%3D" aria-label="CAS reference 32">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2894%2990572-X" aria-label="Article reference 32">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8033212" aria-label="PubMed reference 32" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Cloning%20of%20p27Kip1%2C%20a%20cyclin-dependent%20kinase%20inhibitor%20and%20a%20potential%20mediator%20of%20extracellular%20antimitogenic%20signals&amp;journal=Cell&amp;volume=78&amp;pages=59-66&amp;publication_year=1994&amp;author=Polyak%2CK&amp;author=Lee%2CMH&amp;author=Erdjument-Bromage%2CH&amp;author=Koff%2CA&amp;author=Roberts%2CJM&amp;author=Tempst%2CP&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Toyoshima H, Hunter T: <b>p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.</b>
                                    <i>Cell</i> 1994, <b>78:</b>67â74.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXmsVOmurw%3D" aria-label="CAS reference 33">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2894%2990573-8" aria-label="Article reference 33">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8033213" aria-label="PubMed reference 33" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=p27%2C%20a%20novel%20inhibitor%20of%20G1%20cyclin-Cdk%20protein%20kinase%20activity%2C%20is%20related%20to%20p21&amp;journal=Cell&amp;volume=78&amp;pages=67-74&amp;publication_year=1994&amp;author=Toyoshima%2CH&amp;author=Hunter%2CT">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: <b>p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.</b>
                                    <i>Genes Dev</i> 1995, <b>9:</b>650â662.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXltVWqs7k%3D" aria-label="CAS reference 34">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.9.6.650" aria-label="Article reference 34">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7729684" aria-label="PubMed reference 34" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=p57KIP2%2C%20a%20structurally%20distinct%20member%20of%20the%20p21CIP1%20Cdk%20inhibitor%20family%2C%20is%20a%20candidate%20tumor%20suppressor%20gene&amp;journal=Genes%20Dev&amp;volume=9&amp;pages=650-662&amp;publication_year=1995&amp;author=Matsuoka%2CS&amp;author=Edwards%2CMC&amp;author=Bai%2CC&amp;author=Parker%2CS&amp;author=Zhang%2CP&amp;author=Baldini%2CA&amp;author=Harper%2CJW&amp;author=Elledge%2CSJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Lee MH, Reynisdottir I, Massague J: <b>Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.</b>
                                    <i>Genes Dev</i> 1995, <b>9:</b>639â649.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXltVWqs7g%3D" aria-label="CAS reference 35">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.9.6.639" aria-label="Article reference 35">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7729683" aria-label="PubMed reference 35" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Cloning%20of%20p57KIP2%2C%20a%20cyclin-dependent%20kinase%20inhibitor%20with%20unique%20domain%20structure%20and%20tissue%20distribution&amp;journal=Genes%20Dev&amp;volume=9&amp;pages=639-649&amp;publication_year=1995&amp;author=Lee%2CMH&amp;author=Reynisdottir%2CI&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Sherr CJ, Roberts JM: <b>CDK inhibitors: positive and negative regulators of G1-phase progression.</b>
                                    <i>Genes Dev</i> 1999, <b>13:</b>1501â1512.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1MXktlOhsLs%3D" aria-label="CAS reference 36">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.13.12.1501" aria-label="Article reference 36">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10385618" aria-label="PubMed reference 36" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=CDK%20inhibitors%3A%20positive%20and%20negative%20regulators%20of%20G1-phase%20progression&amp;journal=Genes%20Dev&amp;volume=13&amp;pages=1501-1512&amp;publication_year=1999&amp;author=Sherr%2CCJ&amp;author=Roberts%2CJM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Xiong Y, Zhang H, Beach D: <b>D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.</b>
                                    <i>Cell</i> 1992, <b>71:</b>505â514.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3sXhvVGru7c%3D" aria-label="CAS reference 37">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2F0092-8674%2892%2990518-H" aria-label="Article reference 37">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1358458" aria-label="PubMed reference 37" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=D%20type%20cyclins%20associate%20with%20multiple%20protein%20kinases%20and%20the%20DNA%20replication%20and%20repair%20factor%20PCNA&amp;journal=Cell&amp;volume=71&amp;pages=505-514&amp;publication_year=1992&amp;author=Xiong%2CY&amp;author=Zhang%2CH&amp;author=Beach%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">Yu ZK, Gervais JL, Zhang H: <b>Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.</b>
                                    <i>Proc Natl Acad Sci USA</i> 1998, <b>95:</b>11324â11329.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1cXmt1agtbg%3D" aria-label="CAS reference 38">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.95.19.11324" aria-label="Article reference 38">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9736735" aria-label="PubMed reference 38" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC21641" aria-label="PubMed Central reference 38" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Human%20CUL-1%20associates%20with%20the%20SKP1%2FSKP2%20complex%20and%20regulates%20p21%28CIP1%2FWAF1%29%20and%20cyclin%20D%20proteins&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=95&amp;pages=11324-11329&amp;publication_year=1998&amp;author=Yu%2CZK&amp;author=Gervais%2CJL&amp;author=Zhang%2CH">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Massague J: <b>TGFbeta in Cancer.</b>
                                    <i>Cell</i> 2008, <b>134:</b>215â230.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXptlaltbk%3D" aria-label="CAS reference 39">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2008.07.001" aria-label="Article reference 39">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18662538" aria-label="PubMed reference 39" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512574" aria-label="PubMed Central reference 39" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=TGFbeta%20in%20Cancer&amp;journal=Cell&amp;volume=134&amp;pages=215-230&amp;publication_year=2008&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Reynisdottir I, Polyak K, Iavarone A, Massague J: <b>Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.</b>
                                    <i>Genes Dev</i> 1995, <b>9:</b>1831â1845.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXns1aqtLY%3D" aria-label="CAS reference 40">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.9.15.1831" aria-label="Article reference 40">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7649471" aria-label="PubMed reference 40" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Kip%2FCip%20and%20Ink4%20Cdk%20inhibitors%20cooperate%20to%20induce%20cell%20cycle%20arrest%20in%20response%20to%20TGF-beta&amp;journal=Genes%20Dev&amp;volume=9&amp;pages=1831-1845&amp;publication_year=1995&amp;author=Reynisdottir%2CI&amp;author=Polyak%2CK&amp;author=Iavarone%2CA&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">Seoane J, Le HV, Shen L, Anderson SA, Massague J: <b>Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.</b>
                                    <i>Cell</i> 2004, <b>117:</b>211â223.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXjsFyrurc%3D" aria-label="CAS reference 41">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0092-8674%2804%2900298-3" aria-label="Article reference 41">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15084259" aria-label="PubMed reference 41" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Integration%20of%20Smad%20and%20forkhead%20pathways%20in%20the%20control%20of%20neuroepithelial%20and%20glioblastoma%20cell%20proliferation&amp;journal=Cell&amp;volume=117&amp;pages=211-223&amp;publication_year=2004&amp;author=Seoane%2CJ&amp;author=Le%2CHV&amp;author=Shen%2CL&amp;author=Anderson%2CSA&amp;author=Massague%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Abbas T, Dutta A: <b>p21 in cancer: intricate networks and multiple activities.</b>
                                    <i>Nat Rev Cancer</i> 2009, <b>9:</b>400â414.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXlvFShsb4%3D" aria-label="CAS reference 42">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc2657" aria-label="Article reference 42">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19440234" aria-label="PubMed reference 42" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722839" aria-label="PubMed Central reference 42" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=p21%20in%20cancer%3A%20intricate%20networks%20and%20multiple%20activities&amp;journal=Nat%20Rev%20Cancer&amp;volume=9&amp;pages=400-414&amp;publication_year=2009&amp;author=Abbas%2CT&amp;author=Dutta%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL: <b>Cyclin D as a therapeutic target in cancer.</b>
                                    <i>Nat Rev Cancer</i> 2011, <b>11:</b>558â572.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXos1Srsr0%3D" aria-label="CAS reference 43">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc3090" aria-label="Article reference 43">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21734724" aria-label="PubMed reference 43" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D%20as%20a%20therapeutic%20target%20in%20cancer&amp;journal=Nat%20Rev%20Cancer&amp;volume=11&amp;pages=558-572&amp;publication_year=2011&amp;author=Musgrove%2CEA&amp;author=Caldon%2CCE&amp;author=Barraclough%2CJ&amp;author=Stone%2CA&amp;author=Sutherland%2CRL">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ: <b>A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion.</b>
                                    <i>Breast Cancer Res</i> 2012, <b>14:</b>R127.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xhsl2jsbzI" aria-label="CAS reference 44">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fbcr3322" aria-label="Article reference 44">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22995475" aria-label="PubMed reference 44" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053104" aria-label="PubMed Central reference 44" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20novel%20function%20for%20p21Cip1%20and%20acetyltransferase%20p%2FCAF%20as%20critical%20transcriptional%20regulators%20of%20TGFbeta-mediated%20breast%20cancer%20cell%20migration%20and%20invasion&amp;journal=Breast%20Cancer%20Res&amp;volume=14&amp;publication_year=2012&amp;author=Dai%2CM&amp;author=Al-Odaini%2CAA&amp;author=Arakelian%2CA&amp;author=Rabbani%2CSA&amp;author=Ali%2CS&amp;author=Lebrun%2CJJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT: <b>Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.</b>
                                    <i>Clin Cancer Res</i> 2009, <b>15:</b>3654â3662.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXmsFOjtb4%3D" aria-label="CAS reference 45">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F1078-0432.CCR-08-3293" aria-label="Article reference 45">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19470724" aria-label="PubMed reference 45" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887710" aria-label="PubMed Central reference 45" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Integrative%20analysis%20of%20cyclin%20protein%20levels%20identifies%20cyclin%20b1%20as%20a%20classifier%20and%20predictor%20of%20outcomes%20in%20breast%20cancer&amp;journal=Clin%20Cancer%20Res&amp;volume=15&amp;pages=3654-3662&amp;publication_year=2009&amp;author=Agarwal%2CR&amp;author=Gonzalez-Angulo%2CAM&amp;author=Myhre%2CS&amp;author=Carey%2CM&amp;author=Lee%2CJS&amp;author=Overgaard%2CJ&amp;author=Alsner%2CJ&amp;author=Stemke-Hale%2CK&amp;author=Lluch%2CA&amp;author=Neve%2CRM&amp;author=Kuo%2CWL&amp;author=Sorlie%2CT&amp;author=Sahin%2CA&amp;author=Valero%2CV&amp;author=Keyomarsi%2CK&amp;author=Gray%2CJW&amp;author=Borresen-Dale%2CAL&amp;author=Mills%2CGB&amp;author=Hennessy%2CBT">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46">Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, Knudsen ES: <b>RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.</b>
                                    <i>Cell Cycle</i> 2010, <b>9:</b>4153â4163.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXit1ahurs%3D" aria-label="CAS reference 46">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.4161%2Fcc.9.20.13454" aria-label="Article reference 46">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20948315" aria-label="PubMed reference 46" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055199" aria-label="PubMed Central reference 46" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=RB-pathway%20disruption%20in%20breast%20cancer%3A%20differential%20association%20with%20disease%20subtypes%2C%20disease-specific%20prognosis%20and%20therapeutic%20response&amp;journal=Cell%20Cycle&amp;volume=9&amp;pages=4153-4163&amp;publication_year=2010&amp;author=Ertel%2CA&amp;author=Dean%2CJL&amp;author=Rui%2CH&amp;author=Liu%2CC&amp;author=Witkiewicz%2CAK&amp;author=Knudsen%2CKE&amp;author=Knudsen%2CES">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47">Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C: <b>Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.</b>
                                    <i>Clin Cancer Res</i> 2000, <b>6:</b>1891â1895.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXktVWisLs%3D" aria-label="CAS reference 47">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10815912" aria-label="PubMed reference 47" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Overexpression%20of%20cyclin%20D1%20is%20associated%20with%20metastatic%20prostate%20cancer%20to%20bone&amp;journal=Clin%20Cancer%20Res&amp;volume=6&amp;pages=1891-1895&amp;publication_year=2000&amp;author=Drobnjak%2CM&amp;author=Osman%2CI&amp;author=Scher%2CHI&amp;author=Fazzari%2CM&amp;author=Cordon-Cardo%2CC">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48">Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: <b>PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.</b>
                                    <i>Cancer Res</i> 1994, <b>54:</b>4813â4817.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXlslaiu7s%3D" aria-label="CAS reference 48">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8062283" aria-label="PubMed reference 48" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=PRAD-1%2Fcyclin%20D1%20gene%20amplification%20correlates%20with%20messenger%20RNA%20overexpression%20and%20tumor%20progression%20in%20human%20laryngeal%20carcinomas&amp;journal=Cancer%20Res&amp;volume=54&amp;pages=4813-4817&amp;publication_year=1994&amp;author=Jares%2CP&amp;author=Fernandez%2CPL&amp;author=Campo%2CE&amp;author=Nadal%2CA&amp;author=Bosch%2CF&amp;author=Aiza%2CG&amp;author=Nayach%2CI&amp;author=Traserra%2CJ&amp;author=Cardesa%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49">Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, MassaguÃ© J: <b>Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.</b>
                                    <i>J Clin Invest</i> 2005, <b>115:</b>44â55.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXis1eluw%3D%3D" aria-label="CAS reference 49">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1172%2FJCI22320" aria-label="Article reference 49">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15630443" aria-label="PubMed reference 49" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC539194" aria-label="PubMed Central reference 49" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Distinct%20organ-specific%20metastatic%20potential%20of%20individual%20breast%20cancer%20cells%20and%20primary%20tumors&amp;journal=J%20Clin%20Invest&amp;volume=115&amp;pages=44-55&amp;publication_year=2005&amp;author=Minn%2CAJ&amp;author=Kang%2CY&amp;author=Serganova%2CI&amp;author=Gupta%2CGP&amp;author=Giri%2CDD&amp;author=Doubrovin%2CM&amp;author=Ponomarev%2CV&amp;author=Gerald%2CWL&amp;author=Blasberg%2CR&amp;author=Massagu%C3%A9%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50">Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA: <b>Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.</b>
                                    <i>Mol Cell</i> 2006, <b>24:</b>355â366.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XhtF2qs7jI" aria-label="CAS reference 50">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.molcel.2006.09.007" aria-label="Article reference 50">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17081987" aria-label="PubMed reference 50" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702390" aria-label="PubMed Central reference 50" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=Phosphorylation-dependent%20ubiquitination%20of%20cyclin%20D1%20by%20the%20SCF%28FBX4-alphaB%20crystallin%29%20complex&amp;journal=Mol%20Cell&amp;volume=24&amp;pages=355-366&amp;publication_year=2006&amp;author=Lin%2CDI&amp;author=Barbash%2CO&amp;author=Kumar%2CKG&amp;author=Weber%2CJD&amp;author=Harper%2CJW&amp;author=Klein-Szanto%2CAJ&amp;author=Rustgi%2CA&amp;author=Fuchs%2CSY&amp;author=Diehl%2CJA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."><p class="c-article-references__text" id="ref-CR51">Alt JR, Cleveland JL, Hannink M, Diehl JA: <b>Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.</b>
                                    <i>Genes Dev</i> 2000, <b>14:</b>3102â3114.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXhs1Wgtg%3D%3D" aria-label="CAS reference 51">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.854900" aria-label="Article reference 51">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11124803" aria-label="PubMed reference 51" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC317128" aria-label="PubMed Central reference 51" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=Phosphorylation-dependent%20regulation%20of%20cyclin%20D1%20nuclear%20export%20and%20cyclin%20D1-dependent%20cellular%20transformation&amp;journal=Genes%20Dev&amp;volume=14&amp;pages=3102-3114&amp;publication_year=2000&amp;author=Alt%2CJR&amp;author=Cleveland%2CJL&amp;author=Hannink%2CM&amp;author=Diehl%2CJA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."><p class="c-article-references__text" id="ref-CR52">Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, Pestell RG: <b>Cyclin D1 governs adhesion and motility of macrophages.</b>
                                    <i>Mol Biol Cell</i> 2003, <b>14:</b>2005â2015.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXktFKhsr4%3D" aria-label="CAS reference 52">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1091%2Fmbc.02-07-0102" aria-label="Article reference 52">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12802071" aria-label="PubMed reference 52" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC165093" aria-label="PubMed Central reference 52" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20governs%20adhesion%20and%20motility%20of%20macrophages&amp;journal=Mol%20Biol%20Cell&amp;volume=14&amp;pages=2005-2015&amp;publication_year=2003&amp;author=Neumeister%2CP&amp;author=Pixley%2CFJ&amp;author=Xiong%2CY&amp;author=Xie%2CH&amp;author=Wu%2CK&amp;author=Ashton%2CA&amp;author=Cammer%2CM&amp;author=Chan%2CA&amp;author=Symons%2CM&amp;author=Stanley%2CER&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."><p class="c-article-references__text" id="ref-CR53">Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, Zhang X, Li A, Burbelo P, Stanley ER, Pestell RG: <b>Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling.</b>
                                    <i>Mol Cell Biol</i> 2006, <b>26:</b>4240â4256.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XltlWit7s%3D" aria-label="CAS reference 53">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.02124-05" aria-label="Article reference 53">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16705174" aria-label="PubMed reference 53" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489104" aria-label="PubMed Central reference 53" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20regulates%20cellular%20migration%20through%20the%20inhibition%20of%20thrombospondin%201%20and%20ROCK%20signaling&amp;journal=Mol%20Cell%20Biol&amp;volume=26&amp;pages=4240-4256&amp;publication_year=2006&amp;author=Li%2CZ&amp;author=Wang%2CC&amp;author=Jiao%2CX&amp;author=Lu%2CY&amp;author=Fu%2CM&amp;author=Quong%2CAA&amp;author=Dye%2CC&amp;author=Yang%2CJ&amp;author=Dai%2CM&amp;author=Ju%2CX&amp;author=Zhang%2CX&amp;author=Li%2CA&amp;author=Burbelo%2CP&amp;author=Stanley%2CER&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."><p class="c-article-references__text" id="ref-CR54">Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA: <b>Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.</b>
                                    <i>Cancer Res</i> 2010, <b>70:</b>2105â2114.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXisFWis7k%3D" aria-label="CAS reference 54">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-08-1108" aria-label="Article reference 54">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20179208" aria-label="PubMed reference 54" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917898" aria-label="PubMed Central reference 54" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%2Fcyclin-dependent%20kinase%204%20interacts%20with%20filamin%20A%20and%20affects%20the%20migration%20and%20invasion%20potential%20of%20breast%20cancer%20cells&amp;journal=Cancer%20Res&amp;volume=70&amp;pages=2105-2114&amp;publication_year=2010&amp;author=Zhong%2CZ&amp;author=Yeow%2CWS&amp;author=Zou%2CC&amp;author=Wassell%2CR&amp;author=Wang%2CC&amp;author=Pestell%2CRG&amp;author=Quong%2CJN&amp;author=Quong%2CAA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."><p class="c-article-references__text" id="ref-CR55">Schoumacher M, Goldman RD, Louvard D, Vignjevic DM: <b>Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia.</b>
                                    <i>J Cell Biol</i> 2010, <b>189:</b>541â556.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXlvFyhtbg%3D" aria-label="CAS reference 55">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1083%2Fjcb.200909113" aria-label="Article reference 55">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20421424" aria-label="PubMed reference 55" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867303" aria-label="PubMed Central reference 55" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Actin%2C%20microtubules%2C%20and%20vimentin%20intermediate%20filaments%20cooperate%20for%20elongation%20of%20invadopodia&amp;journal=J%20Cell%20Biol&amp;volume=189&amp;pages=541-556&amp;publication_year=2010&amp;author=Schoumacher%2CM&amp;author=Goldman%2CRD&amp;author=Louvard%2CD&amp;author=Vignjevic%2CDM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."><p class="c-article-references__text" id="ref-CR56">Weaver AM: <b>Invadopodia: specialized cell structures for cancer invasion.</b>
                                    <i>Clin Exp Metastasis</i> 2006, <b>23:</b>97â105.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1007%2Fs10585-006-9014-1" aria-label="Article reference 56">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16830222" aria-label="PubMed reference 56" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Invadopodia%3A%20specialized%20cell%20structures%20for%20cancer%20invasion&amp;journal=Clin%20Exp%20Metastasis&amp;volume=23&amp;pages=97-105&amp;publication_year=2006&amp;author=Weaver%2CAM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."><p class="c-article-references__text" id="ref-CR57">Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG: <b>Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.</b>
                                    <i>Mol Cell Biol</i> 2000, <b>20:</b>672â683.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXjtVKltA%3D%3D" aria-label="CAS reference 57">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.20.2.672-683.2000" aria-label="Article reference 57">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10611246" aria-label="PubMed reference 57" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC85165" aria-label="PubMed Central reference 57" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20is%20required%20for%20transformation%20by%20activated%20Neu%20and%20is%20induced%20through%20an%20E2F-dependent%20signaling%20pathway&amp;journal=Mol%20Cell%20Biol&amp;volume=20&amp;pages=672-683&amp;publication_year=2000&amp;author=Lee%2CRJ&amp;author=Albanese%2CC&amp;author=Fu%2CM&amp;author=D%27Amico%2CM&amp;author=Lin%2CB&amp;author=Watanabe%2CG&amp;author=Haines%2CGK&amp;author=Siegel%2CPM&amp;author=Hung%2CMC&amp;author=Yarden%2CY&amp;author=Horowitz%2CJM&amp;author=Muller%2CWJ&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."><p class="c-article-references__text" id="ref-CR58">Yu Q, Geng Y, Sicinski P: <b>Specific protection against breast cancers by cyclin D1 ablation.</b>
                                    <i>Nature</i> 2001, <b>411:</b>1017â1021.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXltVClu7g%3D" aria-label="CAS reference 58">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F35082500" aria-label="Article reference 58">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11429595" aria-label="PubMed reference 58" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;title=Specific%20protection%20against%20breast%20cancers%20by%20cyclin%20D1%20ablation&amp;journal=Nature&amp;volume=411&amp;pages=1017-1021&amp;publication_year=2001&amp;author=Yu%2CQ&amp;author=Geng%2CY&amp;author=Sicinski%2CP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."><p class="c-article-references__text" id="ref-CR59">Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P: <b>Mouse development and cell proliferation in the absence of D-cyclins.</b>
                                    <i>Cell</i> 2004, <b>118:</b>477â491.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXntlCmu7Y%3D" aria-label="CAS reference 59">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2004.07.025" aria-label="Article reference 59">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15315760" aria-label="PubMed reference 59" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;title=Mouse%20development%20and%20cell%20proliferation%20in%20the%20absence%20of%20D-cyclins&amp;journal=Cell&amp;volume=118&amp;pages=477-491&amp;publication_year=2004&amp;author=Kozar%2CK&amp;author=Ciemerych%2CMA&amp;author=Rebel%2CVI&amp;author=Shigematsu%2CH&amp;author=Zagozdzon%2CA&amp;author=Sicinska%2CE&amp;author=Geng%2CY&amp;author=Yu%2CQ&amp;author=Bhattacharya%2CS&amp;author=Bronson%2CRT&amp;author=Akashi%2CK&amp;author=Sicinski%2CP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."><p class="c-article-references__text" id="ref-CR60">Arnold A, Papanikolaou A: <b>Cyclin D1 in breast cancer pathogenesis.</b>
                                    <i>J Clin Oncol</i> 2005, <b>23:</b>4215â4224.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXmt1els7c%3D" aria-label="CAS reference 60">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1200%2FJCO.2005.05.064" aria-label="Article reference 60">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15961768" aria-label="PubMed reference 60" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20in%20breast%20cancer%20pathogenesis&amp;journal=J%20Clin%20Oncol&amp;volume=23&amp;pages=4215-4224&amp;publication_year=2005&amp;author=Arnold%2CA&amp;author=Papanikolaou%2CA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."><p class="c-article-references__text" id="ref-CR61">Fu M, Wang C, Li Z, Sakamaki T, Pestell RG: <b>Minireview: Cyclin D1: normal and abnormal functions.</b>
                                    <i>Endocrinology</i> 2004, <b>145:</b>5439â5447.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXhtVaqu7zP" aria-label="CAS reference 61">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1210%2Fen.2004-0959" aria-label="Article reference 61">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15331580" aria-label="PubMed reference 61" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;title=Minireview%3A%20Cyclin%20D1%3A%20normal%20and%20abnormal%20functions&amp;journal=Endocrinology&amp;volume=145&amp;pages=5439-5447&amp;publication_year=2004&amp;author=Fu%2CM&amp;author=Wang%2CC&amp;author=Li%2CZ&amp;author=Sakamaki%2CT&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."><p class="c-article-references__text" id="ref-CR62">Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS: <b>A census of amplified and overexpressed human cancer genes.</b>
                                    <i>Nat Rev Cancer</i> 2010, <b>10:</b>59â64.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhsF2hs7bF" aria-label="CAS reference 62">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc2771" aria-label="Article reference 62">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20029424" aria-label="PubMed reference 62" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20census%20of%20amplified%20and%20overexpressed%20human%20cancer%20genes&amp;journal=Nat%20Rev%20Cancer&amp;volume=10&amp;pages=59-64&amp;publication_year=2010&amp;author=Santarius%2CT&amp;author=Shipley%2CJ&amp;author=Brewer%2CD&amp;author=Stratton%2CMR&amp;author=Cooper%2CCS">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."><p class="c-article-references__text" id="ref-CR63">Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Hruban RH, Goggins M: <b>Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.</b>
                                    <i>Clin Cancer Res</i> 2003, <b>9:</b>1446â1452.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXislertLY%3D" aria-label="CAS reference 63">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12684418" aria-label="PubMed reference 63" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;title=Methylation%20of%20cyclin%20D2%20is%20observed%20frequently%20in%20pancreatic%20cancer%20but%20is%20also%20an%20age-related%20phenomenon%20in%20gastrointestinal%20tissues&amp;journal=Clin%20Cancer%20Res&amp;volume=9&amp;pages=1446-1452&amp;publication_year=2003&amp;author=Matsubayashi%2CH&amp;author=Sato%2CN&amp;author=Fukushima%2CN&amp;author=Yeo%2CCJ&amp;author=Walter%2CKM&amp;author=Brune%2CK&amp;author=Sahin%2CF&amp;author=Hruban%2CRH&amp;author=Goggins%2CM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."><p class="c-article-references__text" id="ref-CR64">Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S: <b>Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.</b>
                                    <i>Cancer Res</i> 2001, <b>61:</b>2782â2787.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXisVSktr4%3D" aria-label="CAS reference 64">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11289162" aria-label="PubMed reference 64" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;title=Loss%20of%20cyclin%20D2%20expression%20in%20the%20majority%20of%20breast%20cancers%20is%20associated%20with%20promoter%20hypermethylation&amp;journal=Cancer%20Res&amp;volume=61&amp;pages=2782-2787&amp;publication_year=2001&amp;author=Evron%2CE&amp;author=Umbricht%2CCB&amp;author=Korz%2CD&amp;author=Raman%2CV&amp;author=Loeb%2CDM&amp;author=Niranjan%2CB&amp;author=Buluwela%2CL&amp;author=Weitzman%2CSA&amp;author=Marks%2CJ&amp;author=Sukumar%2CS">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."><p class="c-article-references__text" id="ref-CR65">Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF: <b>Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.</b>
                                    <i>Clin Cancer Res</i> 2003, <b>9:</b>4730â4734.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXosVGjs7c%3D" aria-label="CAS reference 65">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14581343" aria-label="PubMed reference 65" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 65" href="http://scholar.google.com/scholar_lookup?&amp;title=Inactivation%20of%20cyclin%20D2%20gene%20in%20prostate%20cancers%20by%20aberrant%20promoter%20methylation&amp;journal=Clin%20Cancer%20Res&amp;volume=9&amp;pages=4730-4734&amp;publication_year=2003&amp;author=Padar%2CA&amp;author=Sathyanarayana%2CUG&amp;author=Suzuki%2CM&amp;author=Maruyama%2CR&amp;author=Hsieh%2CJT&amp;author=Frenkel%2CEP&amp;author=Minna%2CJD&amp;author=Gazdar%2CAF">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."><p class="c-article-references__text" id="ref-CR66">Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: <b>Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.</b>
                                    <i>Nature</i> 1994, <b>369:</b>669â671.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXksFCqsL4%3D" aria-label="CAS reference 66">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F369669a0" aria-label="Article reference 66">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8208295" aria-label="PubMed reference 66" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 66" href="http://scholar.google.com/scholar_lookup?&amp;title=Mammary%20hyperplasia%20and%20carcinoma%20in%20MMTV-cyclin%20D1%20transgenic%20mice&amp;journal=Nature&amp;volume=369&amp;pages=669-671&amp;publication_year=1994&amp;author=Wang%2CTC&amp;author=Cardiff%2CRD&amp;author=Zukerberg%2CL&amp;author=Lees%2CE&amp;author=Arnold%2CA&amp;author=Schmidt%2CEV">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."><p class="c-article-references__text" id="ref-CR67">Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW: <b>Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.</b>
                                    <i>Cancer Cell</i> 2006, <b>9:</b>13â22.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XosFersg%3D%3D" aria-label="CAS reference 67">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.ccr.2005.12.019" aria-label="Article reference 67">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16413468" aria-label="PubMed reference 67" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1-dependent%20kinase%20activity%20in%20murine%20development%20and%20mammary%20tumorigenesis&amp;journal=Cancer%20Cell&amp;volume=9&amp;pages=13-22&amp;publication_year=2006&amp;author=Landis%2CMW&amp;author=Pawlyk%2CBS&amp;author=Li%2CT&amp;author=Sicinski%2CP&amp;author=Hinds%2CPW">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."><p class="c-article-references__text" id="ref-CR68">Yu Q, Sicinska E, Geng Y, Ahnstrom M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stal O, Sicinski P: <b>Requirement for CDK4 kinase function in breast cancer.</b>
                                    <i>Cancer Cell</i> 2006, <b>9:</b>23â32.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XosFersw%3D%3D" aria-label="CAS reference 68">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.ccr.2005.12.012" aria-label="Article reference 68">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16413469" aria-label="PubMed reference 68" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 68" href="http://scholar.google.com/scholar_lookup?&amp;title=Requirement%20for%20CDK4%20kinase%20function%20in%20breast%20cancer&amp;journal=Cancer%20Cell&amp;volume=9&amp;pages=23-32&amp;publication_year=2006&amp;author=Yu%2CQ&amp;author=Sicinska%2CE&amp;author=Geng%2CY&amp;author=Ahnstrom%2CM&amp;author=Zagozdzon%2CA&amp;author=Kong%2CY&amp;author=Gardner%2CH&amp;author=Kiyokawa%2CH&amp;author=Harris%2CLN&amp;author=Stal%2CO&amp;author=Sicinski%2CP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."><p class="c-article-references__text" id="ref-CR69">Yang C, Ionescu-Tiba V, Burns K, Gadd M, Zukerberg L, Louis DN, Sgroi D, Schmidt EV: <b>The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer.</b>
                                    <i>Am J Pathol</i> 2004, <b>164:</b>1031â1038.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXitl2jt7c%3D" aria-label="CAS reference 69">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0002-9440%2810%2963190-2" aria-label="Article reference 69">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14982856" aria-label="PubMed reference 69" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1614725" aria-label="PubMed Central reference 69" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20role%20of%20the%20cyclin%20D1-dependent%20kinases%20in%20ErbB2-mediated%20breast%20cancer&amp;journal=Am%20J%20Pathol&amp;volume=164&amp;pages=1031-1038&amp;publication_year=2004&amp;author=Yang%2CC&amp;author=Ionescu-Tiba%2CV&amp;author=Burns%2CK&amp;author=Gadd%2CM&amp;author=Zukerberg%2CL&amp;author=Louis%2CDN&amp;author=Sgroi%2CD&amp;author=Schmidt%2CEV">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."><p class="c-article-references__text" id="ref-CR70">Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D: <b>Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.</b>
                                    <i>Oncogene</i> 1999, <b>18:</b>1983â1991.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1MXisVWmtb0%3D" aria-label="CAS reference 70">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1202511" aria-label="Article reference 70">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10208420" aria-label="PubMed reference 70" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20and%20D3%20associate%20with%20the%20SCF%20complex%20and%20are%20coordinately%20elevated%20in%20breast%20cancer&amp;journal=Oncogene&amp;volume=18&amp;pages=1983-1991&amp;publication_year=1999&amp;author=Russell%2CA&amp;author=Thompson%2CMA&amp;author=Hendley%2CJ&amp;author=Trute%2CL&amp;author=Armes%2CJ&amp;author=Germain%2CD">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."><p class="c-article-references__text" id="ref-CR71">Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA: <b>Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.</b>
                                    <i>Oncogene</i> 2006, <b>25:</b>6291â6303.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XhtVKntLbE" aria-label="CAS reference 71">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1209644" aria-label="Article reference 71">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16732330" aria-label="PubMed reference 71" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20mutations%20that%20disrupt%20phosphorylation-dependent%20nuclear%20export%20of%20cyclin%20D1&amp;journal=Oncogene&amp;volume=25&amp;pages=6291-6303&amp;publication_year=2006&amp;author=Benzeno%2CS&amp;author=Lu%2CF&amp;author=Guo%2CM&amp;author=Barbash%2CO&amp;author=Zhang%2CF&amp;author=Herman%2CJG&amp;author=Klein%2CPS&amp;author=Rustgi%2CA&amp;author=Diehl%2CJA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="72."><p class="c-article-references__text" id="ref-CR72">Moreno-Bueno G, Rodriguez-Perales S, Sanchez-Estevez C, Hardisson D, Sarrio D, Prat J, Cigudosa JC, Matias-Guiu X, Palacios J: <b>Cyclin D1 gene (CCND1) mutations in endometrial cancer.</b>
                                    <i>Oncogene</i> 2003, <b>22:</b>6115â6118.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXmvFansb0%3D" aria-label="CAS reference 72">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1206868" aria-label="Article reference 72">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12955092" aria-label="PubMed reference 72" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20gene%20%28CCND1%29%20mutations%20in%20endometrial%20cancer&amp;journal=Oncogene&amp;volume=22&amp;pages=6115-6118&amp;publication_year=2003&amp;author=Moreno-Bueno%2CG&amp;author=Rodriguez-Perales%2CS&amp;author=Sanchez-Estevez%2CC&amp;author=Hardisson%2CD&amp;author=Sarrio%2CD&amp;author=Prat%2CJ&amp;author=Cigudosa%2CJC&amp;author=Matias-Guiu%2CX&amp;author=Palacios%2CJ">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="73."><p class="c-article-references__text" id="ref-CR73">Kim JK, Diehl JA: <b>Nuclear cyclin D1: an oncogenic driver in human cancer.</b>
                                    <i>J Cell Physiol</i> 2009, <b>220:</b>292â296.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXotFagsr4%3D" aria-label="CAS reference 73">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2Fjcp.21791" aria-label="Article reference 73">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19415697" aria-label="PubMed reference 73" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874239" aria-label="PubMed Central reference 73" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 73" href="http://scholar.google.com/scholar_lookup?&amp;title=Nuclear%20cyclin%20D1%3A%20an%20oncogenic%20driver%20in%20human%20cancer&amp;journal=J%20Cell%20Physiol&amp;volume=220&amp;pages=292-296&amp;publication_year=2009&amp;author=Kim%2CJK&amp;author=Diehl%2CJA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="74."><p class="c-article-references__text" id="ref-CR74">Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, Fu M, Leader JE, Quong A, Novikoff PM, Pestell RG: <b>Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function.</b>
                                    <i>Proc Natl Acad Sci USA</i> 2006, <b>103:</b>11567â11572.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XotFegur8%3D" aria-label="CAS reference 74">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.0603363103" aria-label="Article reference 74">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16864783" aria-label="PubMed reference 74" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1518800" aria-label="PubMed Central reference 74" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 74" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20repression%20of%20nuclear%20respiratory%20factor%201%20integrates%20nuclear%20DNA%20synthesis%20and%20mitochondrial%20function&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=103&amp;pages=11567-11572&amp;publication_year=2006&amp;author=Wang%2CC&amp;author=Li%2CZ&amp;author=Lu%2CY&amp;author=Du%2CR&amp;author=Katiyar%2CS&amp;author=Yang%2CJ&amp;author=Fu%2CM&amp;author=Leader%2CJE&amp;author=Quong%2CA&amp;author=Novikoff%2CPM&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="75."><p class="c-article-references__text" id="ref-CR75">Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J, Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C, Pestell R: <b>Cyclin D1 determines mitochondrial function</b>
                                    <b><i>in vivo</i></b>
                                    <b>.</b>
                                    <i>Mol Cell Biol</i> 2006, <b>26:</b>5449â5469.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XmvFyhtL4%3D" aria-label="CAS reference 75">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.02074-05" aria-label="Article reference 75">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16809779" aria-label="PubMed reference 75" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592725" aria-label="PubMed Central reference 75" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 75" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20determines%20mitochondrial%20function%20in%20vivo&amp;journal=Mol%20Cell%20Biol&amp;volume=26&amp;pages=5449-5469&amp;publication_year=2006&amp;author=Sakamaki%2CT&amp;author=Casimiro%2CMC&amp;author=Ju%2CX&amp;author=Quong%2CAA&amp;author=Katiyar%2CS&amp;author=Liu%2CM&amp;author=Jiao%2CX&amp;author=Li%2CA&amp;author=Zhang%2CX&amp;author=Lu%2CY&amp;author=Wang%2CC&amp;author=Byers%2CS&amp;author=Nicholson%2CR&amp;author=Link%2CT&amp;author=Shemluck%2CM&amp;author=Yang%2CJ&amp;author=Fricke%2CST&amp;author=Novikoff%2CPM&amp;author=Papanikolaou%2CA&amp;author=Arnold%2CA&amp;author=Albanese%2CC&amp;author=Pestell%2CR">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="76."><p class="c-article-references__text" id="ref-CR76">Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, Novikoff PM, Brownlee M, Scherer PE, Jones JG, Whitney KD, Donehower LA, Harris EL, Rohan T, Johns DC, Pestell RG: <b>Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.</b>
                                    <i>Mol Cell Biol</i> 2003, <b>23:</b>6159â6173.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXms1Oht7w%3D" aria-label="CAS reference 76">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.23.17.6159-6173.2003" aria-label="Article reference 76">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12917338" aria-label="PubMed reference 76" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC180960" aria-label="PubMed Central reference 76" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20repression%20of%20peroxisome%20proliferator-activated%20receptor%20gamma%20expression%20and%20transactivation&amp;journal=Mol%20Cell%20Biol&amp;volume=23&amp;pages=6159-6173&amp;publication_year=2003&amp;author=Wang%2CC&amp;author=Pattabiraman%2CN&amp;author=Zhou%2CJN&amp;author=Fu%2CM&amp;author=Sakamaki%2CT&amp;author=Albanese%2CC&amp;author=Li%2CZ&amp;author=Wu%2CK&amp;author=Hulit%2CJ&amp;author=Neumeister%2CP&amp;author=Novikoff%2CPM&amp;author=Brownlee%2CM&amp;author=Scherer%2CPE&amp;author=Jones%2CJG&amp;author=Whitney%2CKD&amp;author=Donehower%2CLA&amp;author=Harris%2CEL&amp;author=Rohan%2CT&amp;author=Johns%2CDC&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="77."><p class="c-article-references__text" id="ref-CR77">Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M: <b>Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.</b>
                                    <i>Clin Cancer Res</i> 2006, <b>12:</b>4720â4729.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XnvVGksLk%3D" aria-label="CAS reference 77">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F1078-0432.CCR-05-1213" aria-label="Article reference 77">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16899623" aria-label="PubMed reference 77" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 77" href="http://scholar.google.com/scholar_lookup?&amp;title=Antisense%20to%20cyclin%20D1%20inhibits%20vascular%20endothelial%20growth%20factor-stimulated%20growth%20of%20vascular%20endothelial%20cells%3A%20implication%20of%20tumor%20vascularization&amp;journal=Clin%20Cancer%20Res&amp;volume=12&amp;pages=4720-4729&amp;publication_year=2006&amp;author=Yasui%2CM&amp;author=Yamamoto%2CH&amp;author=Ngan%2CCY&amp;author=Damdinsuren%2CB&amp;author=Sugita%2CY&amp;author=Fukunaga%2CH&amp;author=Gu%2CJ&amp;author=Maeda%2CM&amp;author=Takemasa%2CI&amp;author=Ikeda%2CM&amp;author=Fujio%2CY&amp;author=Sekimoto%2CM&amp;author=Matsuura%2CN&amp;author=Weinstein%2CIB&amp;author=Monden%2CM">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="78."><p class="c-article-references__text" id="ref-CR78">Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG: <b>Cyclin D1 induction of cellular migration requires p27(KIP1).</b>
                                    <i>Cancer Res</i> 2006, <b>66:</b>9986â9994.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XhtVyiurrF" aria-label="CAS reference 78">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-06-1596" aria-label="Article reference 78">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17047061" aria-label="PubMed reference 78" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 78" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20D1%20induction%20of%20cellular%20migration%20requires%20p27%28KIP1%29&amp;journal=Cancer%20Res&amp;volume=66&amp;pages=9986-9994&amp;publication_year=2006&amp;author=Li%2CZ&amp;author=Jiao%2CX&amp;author=Wang%2CC&amp;author=Ju%2CX&amp;author=Lu%2CY&amp;author=Yuan%2CL&amp;author=Lisanti%2CMP&amp;author=Katiyar%2CS&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="79."><p class="c-article-references__text" id="ref-CR79">Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP, Sicinski P: <b>A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.</b>
                                    <i>Nature</i> 2011, <b>474:</b>230â234.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXntFKktLg%3D" aria-label="CAS reference 79">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnature10155" aria-label="Article reference 79">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21654808" aria-label="PubMed reference 79" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134411" aria-label="PubMed Central reference 79" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 79" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20function%20for%20cyclin%20D1%20in%20DNA%20repair%20uncovered%20by%20protein%20interactome%20analyses%20in%20human%20cancers&amp;journal=Nature&amp;volume=474&amp;pages=230-234&amp;publication_year=2011&amp;author=Jirawatnotai%2CS&amp;author=Hu%2CY&amp;author=Michowski%2CW&amp;author=Elias%2CJE&amp;author=Becks%2CL&amp;author=Bienvenu%2CF&amp;author=Zagozdzon%2CA&amp;author=Goswami%2CT&amp;author=Wang%2CYE&amp;author=Clark%2CAB&amp;author=Kunkel%2CTA&amp;author=van%20Harn%2CT&amp;author=Xia%2CB&amp;author=Correll%2CM&amp;author=Quackenbush%2CJ&amp;author=Livingston%2CDM&amp;author=Gygi%2CSP&amp;author=Sicinski%2CP">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="80."><p class="c-article-references__text" id="ref-CR80">Alt JR, Gladden AB, Diehl JA: <b>p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export.</b>
                                    <i>J Biol Chem</i> 2002, <b>277:</b>8517â8523.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XitFymtbc%3D" aria-label="CAS reference 80">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.M108867200" aria-label="Article reference 80">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11751903" aria-label="PubMed reference 80" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 80" href="http://scholar.google.com/scholar_lookup?&amp;title=p21%28Cip1%29%20Promotes%20cyclin%20D1%20nuclear%20accumulation%20via%20direct%20inhibition%20of%20nuclear%20export&amp;journal=J%20Biol%20Chem&amp;volume=277&amp;pages=8517-8523&amp;publication_year=2002&amp;author=Alt%2CJR&amp;author=Gladden%2CAB&amp;author=Diehl%2CJA">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="81."><p class="c-article-references__text" id="ref-CR81">Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O, Wang M, Soutoglou E, Knudsen ES, Pestell RG: <b>Alternative cyclin D1 splice forms differentially regulate the DNA damage response.</b>
                                    <i>Cancer Res</i> 2010, <b>70:</b>8802â8811.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtlKjt7zN" aria-label="CAS reference 81">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-10-0312" aria-label="Article reference 81">Article</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20940395" aria-label="PubMed reference 81" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970762" aria-label="PubMed Central reference 81" rel="nofollow">PubMed Central</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 81" href="http://scholar.google.com/scholar_lookup?&amp;title=Alternative%20cyclin%20D1%20splice%20forms%20differentially%20regulate%20the%20DNA%20damage%20response&amp;journal=Cancer%20Res&amp;volume=70&amp;pages=8802-8811&amp;publication_year=2010&amp;author=Li%2CZ&amp;author=Jiao%2CX&amp;author=Wang%2CC&amp;author=Shirley%2CLA&amp;author=Elsaleh%2CH&amp;author=Dahl%2CO&amp;author=Wang%2CM&amp;author=Soutoglou%2CE&amp;author=Knudsen%2CES&amp;author=Pestell%2CRG">
                    Google Scholar</a>Â 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="82."><p class="c-article-references__text" id="ref-CR82">Raderschall E, Bazarov A, Cao J, Lurz R, Smith A, Mann W, Ropers HH, Sedivy JM, Golub EI, Fritz E, Haaf T: <b>Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis.</b>
                                    <i>J Cell Sci</i> 2002, <b>115:</b>153â164.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XovVeitQ%3D%3D" aria-label="CAS reference 82">CAS</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11801733" aria-label="PubMed reference 82" rel="nofollow">PubMed</a>Â 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 82" href="http://scholar.google.com/scholar_lookup?&amp;title=Formation%20of%20higher-order%20nuclear%20Rad51%20structures%20is%20functionally%20linked%20to%20p21%20expression%20and%20protection%20from%20DNA%20damage-induced%20apoptosis&amp;journal=J%20Cell%20Sci&amp;volume=115&amp;pages=153-164&amp;publication_year=2002&amp;author=Raderschall%2CE&amp;author=Bazarov%2CA&amp;author=Cao%2CJ&amp;author=Lurz%2CR&amp;author=Smith%2CA&amp;author=Mann%2CW&amp;author=Ropers%2CHH&amp;author=Sedivy%2CJM&amp;author=Golub%2CEI&amp;author=Fritz%2CE&amp;author=Haaf%2CT">
                    Google Scholar</a>Â 
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" href="https://citation-needed.springer.com/v2/references/10.1186/bcr3441?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>Canadian Institutes of Health Research (CIHR) grant (fund code 230670 to JJL) provided the funding for this study. JJ Lebrun is the recipient of a McGill Sir William Dawson Research Chair. Ms. M. Dai is supported by a Fonds de la recherche en santÃ© du QuÃ©bec (FRSQ) Scholarship Award. We thank Dr. Joan MassaguÃ© for kindly providing us the MDA and SCP2 cell lines and Dr. Stephen P Ethier for kindly providing us the SUM1315MO<sub>2,</sub> SUM149PT, and SUM159PT cell lines.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff7"><p class="c-article-author-affiliation__address">Division of Medical Oncology, Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, QC, Canada</p><p class="c-article-author-affiliation__authors-list">Meiou Dai,Â Amal A Al-Odaini,Â NadÃ¨ge Fils-AimÃ©,Â Manuel A Villatoro,Â Jimin Guo,Â Suhad AliÂ &amp;Â Jean Jacques Lebrun</p></li><li id="Aff8"><p class="c-article-author-affiliation__address">University of Dammam, Ministry of Higher Education, Kragujevac, Saudi Arabia</p><p class="c-article-author-affiliation__authors-list">Amal A Al-Odaini</p></li><li id="Aff9"><p class="c-article-author-affiliation__address">Department of Medicine, McGill University Health Center, Royal Victoria Hospital, Montreal, QC, Canada</p><p class="c-article-author-affiliation__authors-list">Ani ArakelianÂ &amp;Â Shafaat A Rabbani</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Meiou-Dai"><span class="c-article-authors-search__title u-h3 js-search-name">Meiou Dai</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Meiou%20Dai%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Meiou%20Dai" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Meiou%20Dai%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Amal_A-Al_Odaini"><span class="c-article-authors-search__title u-h3 js-search-name">Amal A Al-Odaini</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Amal%20A%20Al-Odaini%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Amal%20A%20Al-Odaini" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Amal%20A%20Al-Odaini%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Nad_ge-Fils_Aim_"><span class="c-article-authors-search__title u-h3 js-search-name">NadÃ¨ge Fils-AimÃ©</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Nad%C3%A8ge%20Fils-Aim%C3%A9%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Nad%C3%A8ge%20Fils-Aim%C3%A9" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Nad%C3%A8ge%20Fils-Aim%C3%A9%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Manuel_A-Villatoro"><span class="c-article-authors-search__title u-h3 js-search-name">Manuel A Villatoro</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Manuel%20A%20Villatoro%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Manuel%20A%20Villatoro" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Manuel%20A%20Villatoro%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Jimin-Guo"><span class="c-article-authors-search__title u-h3 js-search-name">Jimin Guo</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Jimin%20Guo%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Jimin%20Guo" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Jimin%20Guo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Ani-Arakelian"><span class="c-article-authors-search__title u-h3 js-search-name">Ani Arakelian</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Ani%20Arakelian%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ani%20Arakelian" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ani%20Arakelian%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Shafaat_A-Rabbani"><span class="c-article-authors-search__title u-h3 js-search-name">Shafaat A Rabbani</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Shafaat%20A%20Rabbani%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Shafaat%20A%20Rabbani" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Shafaat%20A%20Rabbani%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Suhad-Ali"><span class="c-article-authors-search__title u-h3 js-search-name">Suhad Ali</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Suhad%20Ali%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Suhad%20Ali" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Suhad%20Ali%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Jean_Jacques-Lebrun"><span class="c-article-authors-search__title u-h3 js-search-name">Jean Jacques Lebrun</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Jean%20Jacques%20Lebrun%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Jean%20Jacques%20Lebrun" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide">Â </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Jean%20Jacques%20Lebrun%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:jj.lebrun@mcgill.ca">Jean Jacques Lebrun</a>.</p></div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><h3 class="c-article__sub-heading">Competing interests</h3><p>The authors declare that they have no competing interests.</p><h3 class="c-article__sub-heading">Authors' contributions</h3><p>MD and JJL were involved in designing all experiments, and analyzing and interpreting data. MD performed the experiments and wrote the manuscript. JG was involved in the immunofluoresent experiment. NFA was involved in the cell migration experiment. MAV participated in the immunohistochemistry experiment. JJL, NFA, MAV and SA assisted in drafting and editing the manuscript. SA was involved in the study design and result analysis and interpretation. AAA analyzed tumor local invasiveness. SAR and AA performed <i>in vivo</i> studies and analyzed the mammary tumor growth. All authors read and approved the final manuscript.</p><p>An erratum to this article is available at <a href="http://dx.doi.org/10.1186/s13058-017-0831-8">http://dx.doi.org/10.1186/s13058-017-0831-8</a>.</p></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content"><p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Cyclin%20D1%20cooperates%20with%20p21%20to%20regulate%20TGF%CE%B2-mediated%20breast%20cancer%20cell%20migration%20and%20tumor%20local%20invasion&amp;author=Meiou%20Dai%20et%20al&amp;contentID=10.1186%2Fbcr3441&amp;copyright=Dai%20et%20al.%3B%20licensee%20BioMed%20Central%20Ltd.&amp;publication=1465-542X&amp;publicationDate=2013-06-20&amp;publisherName=SpringerNature&amp;orderBeanReset=true">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Dai, M., Al-Odaini, A.A., Fils-AimÃ©, N. <i>et al.</i> Cyclin D1 cooperates with p21 to regulate TGFÎ²-mediated breast cancer cell migration and tumor local invasion.
                    <i>Breast Cancer Res</i> <b>15, </b>3246 (2013). https://doi.org/10.1186/bcr3441</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" href="https://citation-needed.springer.com/v2/references/10.1186/bcr3441?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-12-06">06 December 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Revised<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2013-04-10">10 April 2013</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2013-06-20">20 June 2013</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2013-06-20">20 June 2013</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1186/bcr3441</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span>Cyclin D1</span></li><li class="c-article-subject-list__subject"><span>p21Cip1</span></li><li class="c-article-subject-list__subject"><span>Transforming growth factor beta (TGFÎ²)</span></li><li class="c-article-subject-list__subject"><span>Breast cancer</span></li><li class="c-article-subject-list__subject"><span>Migration</span></li><li class="c-article-subject-list__subject"><span>Invasion</span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>

                    


                </article>
            </main>

            <div class="c-article-extras u-text-sm u-hide-print" data-track-component="reading companion">
                <aside>
                    
    <div class="c-pdf-download u-clear-both">
        <a href="//breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3441.pdf" class="c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>

                    

                    
    


                    <div class="c-reading-companion">
                        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
                            <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                                <div class="js-ad">
    
    <aside class="adsbox c-ad c-ad--300x250 u-mt-16" data-component-mpu>
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-MPU1"
                data-ad-type="MPU1"
                data-pa11y-ignore
                data-gpt
                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"
                data-gpt-sizes="300x250"
                data-gpt-targeting="pos=MPU1;doi=10.1186/bcr3441;type=article;kwrd=Cyclin D1,p21Cip1,Transforming growth factor beta (TGFÎ²),Breast cancer,Migration,Invasion;pmc=B11001,H33160,H59150;"
            >
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/bcr3441&amp;type=article&amp;kwrd=Cyclin D1,p21Cip1,Transforming growth factor beta (TGFÎ²),Breast cancer,Migration,Invasion&amp;pmc=B11001,H33160,H59150&amp;">
                        <img data-test="gpt-advert-fallback-img"
                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/bcr3441&amp;type=article&amp;kwrd=Cyclin D1,p21Cip1,Transforming growth factor beta (TGFÎ²),Breast cancer,Migration,Invasion&amp;pmc=B11001,H33160,H59150&amp;"
                            alt="Advertisement"
                            width="300"
                            height="250">
                    </a>
                </noscript>
            </div>
        </div>
    </aside>
</div>
                            </div>
                            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
                            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
                        </div>
                    </div>
                </aside>
            </div>

        </div>


        
            <div class="c-journal-footer">
                <div class="c-journal-footer__inner">
                    <div class="c-journal-footer__summary">
                        <h4 class="c-journal-title c-journal-title--footer">
                            
                            <span class="c-journal-title__text">Breast Cancer Research</span>
                        </h4>
                         <p class="c-journal-footer__issn">ISSN: 1465-542X</p>
                    </div>
                    
                        <div class="c-journal-footer__contact">
                            <h4 class="c-journal-footer__contact-title ">Contact us</h4>
                            <ul class="c-journal-footer__contact-list">
                                
                                    <li class="c-journal-footer__contact-item">Submission enquiries: <a href="mailto:maritess.reyes@springernature.com">maritess.reyes@springernature.com</a></li>
                                
                                
                                    <li class="c-journal-footer__contact-item">General enquiries: <a href="mailto:info@biomedcentral.com">info@biomedcentral.com</a></li>
                                
                            </ul>
                        </div>
                    
                </div>
            </div>
        
        
    <img rel="nofollow" class='tracker' style='display:none' src='/track/article/10.1186/bcr3441' alt=""/>

         
    <footer>
        
            <div class="c-publisher-footer" data-test="publisher-footer">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test="publisher-footer-menu">
            <div class="u-display-flex">
                
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://blogs.biomedcentral.com/">Read more on our blogs</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/login">Receive BMC newsletters</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/account">Manage article alerts</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://authorservices.springernature.com/go/10BMC">Language editing for authors</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://authorservices.springernature.com/scientific-editing/">Scientific editing for authors</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/policies">Policies</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/accessibility">Accessibility</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/press-centre">Press center</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://support.biomedcentral.com/support/home">Support and Contact</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://biomedcentral.typeform.com/to/VLXboo">Leave feedback</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/jobs">Careers</a>
                                </li>
                            
                        </ul>
                    
                
            </div>
            <div class="u-mb-24">
                <h3 id="social-menu" class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
                <ul class="u-display-flex u-list-reset" data-test="footer-social-links">
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="https://twitter.com/biomedcentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Twitter"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Twitter page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-twitter-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="https://www.facebook.com/BioMedCentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Facebook"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Facebook page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-facebook-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="http://www.weibo.com/biomedcentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Weibo"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Weibo page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-weibo-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </div>
        <p class="u-reset-margin">
            By using this website, you agree to our
            <a class="u-gray-link" href="//www.biomedcentral.com/terms-and-conditions">Terms and Conditions</a>,
            <a class="u-gray-link" href="https://www.springernature.com/ccpa">California Privacy Statement</a>,
            <a class="u-gray-link" href="//www.biomedcentral.com/privacy-statement">Privacy
                statement</a> and
            <a class="u-gray-link" href="//www.biomedcentral.com/cookies" data-test="cookie-link">Cookies</a> policy.
            
                <a class="optanon-toggle-display u-gray-link" data-cc-action="preferences" href="javascript:void(0);">Manage cookies/Do not sell my data</a> we use in the preference centre.
            
        </p>
    </div>
</div>

        
        <div class="c-corporate-footer">
    <div class="u-container">
        <img src=/static/images/logo-springernature-acb40b85fb.svg class="c-corporate-footer__logo" alt="Springer Nature" itemprop="logo" role="img">
        <p class="c-corporate-footer__legal" data-test="copyright"> &#169; 2022 BioMed Central Ltd unless otherwise stated. Part of
            <a class="c-corporate-footer__link" href="https://www.springernature.com" itemscope itemtype="http://schema.org/Organization" itemid="#parentOrganization">Springer Nature</a>.
        </p>
    </div>
</div>

    </footer>

    </div>



        
    <svg class="u-hide hide">
        <symbol id="global-icon-chevron-right" viewBox="0 0 16 16">
            <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-download" viewBox="0 0 16 16">
            <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-email" viewBox="0 0 18 18">
            <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-institution" viewBox="0 0 18 18">
            <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-search" viewBox="0 0 22 22">
            <path fill-rule="evenodd" d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"/>
        </symbol>
        <symbol id="icon-info" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-success" viewBox="0 0 18 18">
            <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-chevron-down" viewBox="0 0 16 16">
            <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/>
        </symbol>
        <symbol id="icon-warning" viewBox="0 0 18 18">
            <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-plus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-minus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-error" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill="currentColor" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-springer-arrow-left">
            <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/>
        </symbol>
        <symbol id="icon-springer-arrow-right">
            <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/>
        </symbol>
    </svg>

    </body>
</html>

